
















MASTER OF MEDICINE IN ANAESTHESIA 
BERNHARD J .C.J. RIEDEL, MB.ChB, FCA (SA). 
DEPARTMENT OF ANAESTHESIA 
FACULTY OF MEDICINE 












The copyright of this thesis vests in the author. No 
quotation from it or information derived from it is to be 
published without full acknowledgement of the source. 
The thesis is to be used for private study or non-
commercial research purposes only. 
 
Published by the University of Cape Town (UCT) in terms 












TABLE OF ABBREVIATIONS 
I. PREFACE AND ACKNOWLEDGEMENTS 
II. BACKGROUND 
A. Introduction 
B. Potential benefits 
C. Potential adverse effects 
D. Summary 
E. Hypothesis 
III. GENERAL METHODOLOGY 
A. Patients 
B. Conduct of anaesthesia and surgery 
1. Thoracic epidural analgesia technique 
2. General anaesthesia technique 
C. Cardiopulmonary bypass & myocardial preservation 
D. Experimental protocol 
1. Parameters of sympatholysis 
2. Parameters of stress response attenuation 
3. Parameters of analgesia & fast-tracking 
E. Data and statistical analyses 
III. RESULTS 
A. Demographics 
B. Parameters of sympatholysis 
C. Parameters of stress response attenuation 
































TABLE OF ABBREVIATIONS 
ACE: angiotensin-converting enzyme 
ACT: activated coagulation time 
CABG: coronary artery bypass graft surgery 
CAD: coronary artery disease 
CI: cardiac index 
CK: creatine kinase 
CK-MB: creatine kinase - MB isoenzyme 
CO: cardiac output 
CPB: cardiopulmonary bypass 
cTn-I: cardiac troponin-I isoform 
CVP: central venous pressure 
ECG: electrocardiograph 
GA: general anaesthesia 
IHD: ischaemic heart disease 
ITU: intensive therapy (care) unit 
LM WH: low molecular weight heparin 
LVSWI: left ventricular stroke work index 
MAP: mean arterial pressure 
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MPAP: mean pulmonary artery pressure 
MI: myocardial infarction 
MIDCAB: minimally invasive direct vision coronary artery bypass surgery 
NSAID: non steroidal anti-inflammatory drug 
NYHA: New York Heart Association functional class 
PAI-1: plasminogen activator inhibitor-1 
PAOP: pulmonary artery occlusion (wedge) pressure 
P-MI: perioperative myocardial infarction 
PTCA: percutaneous transluminal coronary angioplasty 
PVRI: pulmonary vascular resistance index 
SPECT: technetium-pyrophosphate scanning 
SVRI: systemic vascular resistance index 
TEA: thoracic epidural analgesia 
TEG: thromboelastography 
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I.PREFACE AND ACKNOWLEDGEMENT 
It has been suggested that, in addition to superlative analgesia, regional 
anaesthetic and analgesic techniques may reduce surgical stress-induced 
alterations of organ function thereby contributing to accelerated recovery 
following surgery. For example, the specific blockade of nociceptive reflex 
arches by using thoracic epidural analgesic (TEA) techniques may improve 
the following stress-induced alterations of organ function; 
i) improved pulmonary function (the superior pain relief - allows patients to 
breathe and cough sufficiently), 
ii) improved recovery of gastrointestinal function after upper abdominal 
surgery - thereby reducing the risk of bacterial translocation, and 
iii) a decrease in graft occlusion rate following vascular surgery. 
It is therefore unsurprising that regional techniques, which can be 
performed safely in most patients when contraindications are carefully 
observed, are widely used either alone or as an adjuvant anaesthetic and 
postoperative analgesic technique in most surgical disciplines. 
The perception of many anaesthetists, that there is less risk of 
traumatising the spinal cord in the lumbar region has led to this being the 
preferred site of neuraxial instrumentation. However, it is important to note 
that many of the positive effects of regional analgesia (especially epidural 
analgesia) are forgone at this level. In fact, if there is insufficient rostral 
spread of a lumbar epidural block above the fifth thoracic level, it is 
suggested that cardiac complications can occur due to reflex activation and 
sympathetic outflow in the unblocked thoracic region. This has led to 
renewed interest in thoracic epidural techniques, especially in patients 
suffering from ischaemic heart disease (IHD) or other forms of cardiac 
disease, as they may possibly benefit the most from the advantages of 
this technique viz., 
• stress response attenuation 
• sympatholysis , 
• superlative analgesia. 
In fact, the benefits of TEA in IHD were subsequently supported when 
Blomberg et. al [1992] showed that TEA provided selective vasodilation 
of atherosclerotic coronary arteries without inducing coronary steal. 
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The paradox of cardiac anaesthesia lies in the fact that patients with 
ischaemic heart disease scheduled for coronary artery bypass graft 
(CABG) surgery would most likely benefit the most from TEA, however, 
cardiac surgery has traditionally been regarded as an absolute contra-
indication to this technique. This contraindication relates to the potential 
risk of epidural haematoma formation in these patients who are on aspirin 
therapy, as well as needing full systemic heparinisation to facilitate 
cardiopulmonary bypass (CPB). 
On reviewing the medical literature, there is a clear resurgence of 
interest in the use of TEA in cardiac anaesthesia. This resurgence was 
brought about by laboratory-based evidence that TEA-induced 
sympatholysis may be cardioprotective through the promotion of 
myocardial blood flow to areas at-risk and subsequent early, small clinical 
studies suggesting that TEA was feasible, and possibly also beneficial in 
CABG surgery [Joachimsson et. al, 1989; Liem (1-3) et. al, 1992; Stenseth 
et. al, 1994]. 
Despite the positive results of these early studies and suggestions that 
TEA may be the preferred anaesthetic/analgesic technique in select 
groups of patients (promoting early extubation and fast-tracking) 
undergoing cardiac surgery, many anaesthetists are still reluctant, 
however, to use this technique because of the theoretical increased risk 
of the patient suffering a spinal haematoma and subsequent paraplegia. 
In order to outweigh this theoretical risk it is important that we show 
that added benefit, in addition to the provision of analgesia and 
expedited postoperative convalescence, can be obtained by using TEA. 
It is therefore our duty as anaesthetists and perioperative physicians to 
determine whether TEA may also affect the pathophysiology of the 
disease process, especially in the perioperative period - and thereby 
influencing the subsequent long term outcome and quality of life of the 
patient. An example of this latter point would be the potential role of 
TEA in; 
• reducing the incidence of perioperative myocardial infarction (P-MI), 
through the suggested cardioprotective effects of TEA, 
• reducing the incidence of early postoperative graft failure, through 
either; 
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* reduction of native coronary artery and/or graft (conduit) 
spasm, or 
* reduction of postoperative hypercoagulability. 
Furthermore, we as anaesthetists should firmly establish the risk-
benefit ratio of this technique and gain proficiency in the management of 
the patient with a TEA before cardiac units are lured into routine use of 
TEA in an attempt to facilitate early extubation and 'fast-tracking' 
through their intensive therapy units in this era where 'fast-tracking' is 
encouraged by a cost-saving driven economic climate, rather than on pure 
clinical grounds. 
During my postgraduate training years in anaesthesia, under the 
privileged supervision of Professor M. F. M. James (Head, Department of 
Anaesthetics, Groote Schuur Hospital & University of Cape Town, South 
Africa) I developed a special interest in the fields of regional and cardiac 
anaesthesia. These formative years spent in postgraduate anaesthetic 
training coincided with numerous medical and political events that helped 
promote this interest, these included; 
• a resurgence of interest in regional anaesthesia for cardiac surgery, 
• an ongoing search for anaesthetic techniques that allow for 
cardioprotection and facilitation of fast-tracking in cardiac surgery, 
• a changing health policy in the new South Africa, with diminishing 
funding for academic-based tertiary medicine, bought on by a shift of 
emphasis towards a much needed primary health care. 
It was therefore a natural process to want to investigate the role of TEA 
in the setting of cardiac surgery, attempting to find where this technique 
fits into both the medical and economical realms of everyday clinical 
practice. 
Under the guidance of Dr David Royston (Consultant Anaesthetist, Royal 
Brompton & Ha ref ield NHS Trust and Senior Lecturer, Department of 
Anaesthetics, St George's Medical School, University of London, UK) we 
set out to design a pilot study, of which the primary aim was to confirm 
or refute the role of TEA in cardiac surgery. 
This pilot study was designed to; 
• investigate whether a favourable risk-benefit ratio exists or not - i.e. 
whether the theoretical increase in risk of epidural haematoma is 
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outweighed by provision of a potentially more favourable perioperative 
physiological milieu viz., stress response attenuation, sympatholysis and 
superlative analgesia. 
• investigate whether an opioid-free technique could improve 
postoperative recovery, with improved haemodynamic stability, earlier 
extubation and facilitated patient fast-tracking. 
• subsequently identify the subgroup of patients that would benefit the 
most from this technique, thereby allowing us to design a larger 
prospective, randomised trial which would allow us to investigate the more 
important issue of whether the promotion of a more favourable 
perioperative physiological milieu could translate into myocardial 
protection and/or graft protection, with an improved outcome for the 
population as a whole (evidence-based medicine). 
Undoubtedly any study of this magnitude requires assistance from 
various clinical and laboratory persons and I am therefore grateful to : 
Professor George Hall (Head, Department of Anaesthesia, St George's 
Medical School, University of London, UK), a world authority on the 
reduction of the perioperative stress response, for his guidance in 
designing this pilot study, as well as for allowing us access to his 
laboratory; Mr Marcus Haw (Senior Lecturer & Honorary Consultant 
Cardiac Surgeon, Royal Brampton & Harefield NHS Trust, UK) for his 
enthusiasm and willingness to adapt to and subsequently prefer this 
technique during cardiac surgery; and to members of the following 
departments for their ongoing help in processing specimens; 
• Department of Anaesthesia (especially Dr Fionnuala Lyons), Royal 
Brampton & Harefield NHS Trust, UK. 
• Department of Anaesthesia (especially Annette Bryant) 
• St George's Medical School, University of London, UK. 
• Department of Biochemistry (especially Dr Frank Murphy), Royal 
Brampton & Harefield NHS Trust, UK. 
• Department of Cardiology, (especially Yvonne Stern) Northwick Park 
Hospital, UK. 
• School of Biomedical Sciences (especially David Forster), Queens 
Medical Centre, University of Nottingham, UK. 
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II. BACKGROUND 
A. Introduction 
Effective analgesia together with hormonal stress-response suppression is 
suggested to have favourable associations with postoperative outcome in 
noncardiac surgery [Yeager et. al, 1987; Tuman et. al, 1991; Lui et. al, 1995]. 
This possible reduction in morbidity and mortality rates relates to the 
reduction in adverse hemodynamic, metabolic, immunologic, and hemostatic 
alterations [Roizen, 1988; Kehlet, 1989; Weissman, 1990]. 
Aggressive postoperative pain management and stress-response attenuation 
may also be of benefit in cardiac surgery, with a decrease in morbidity and 
mortality rates [Mangano et. al, 1992; Anand et. al, 1992]. 
With the possible exception of remifentanil, however, high-dose opioids 
alone or in combination with other pharmacological agents (e.g. ganglion 
blockers [Desborough et. al, 1990] ) have proved insufficient in preventing 
the hormonal changes related to cardiopulmonary bypass (CPB). Procedures 
directed at the sympathetic nervous system may have benefits extending 
beyond superlative analgesia, with a reduction in surgical stress-induced 
alterations of organ function thereby contributing to accelerated recovery 
in the postoperative period. These and other factors have lead to an 
increasing interest in the use of TEA for patients undergoing coronary 
artery bypass graft (CABG) surgery [Liem et. al, 1992; Stenseth et. al, 1994; 
Moore et. al, 1995]. 
Catecholamine responses to CPB were abolished in patients who received 
TEA in addition to intravenous sufentanil [Moore et. al, 1995]. The epidural 
technique (as high as C7-Tl or Tl-T2) in combination with full intraoperative 
heparinisation, however, lends itself to potentially serious adverse effects, 
the most devastating of which is the formation of an epidural haematoma 
resulting in an irreversible neurologic deficit, such as paraplegia or worse 
still, ventilator dependency. Other adverse effects could potentially include 
epidural abscess formation, dural puncture, respiratory depression and poor 
epidural positioning with a detrimental increase in sympathetic outflow. 
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It is therefore crucial that TEA be used with great caution in selected 
patients, that the risks and benefits be firmly established, and that further 
clinical trials be conducted before it becomes routine clinical practice. 
B. Potential benefits 
To establish whether the haemodynamic, metabolic, immunologic, and 
haemostatic effects of TEA, brought about by improved stress response 
attenuation, sympatholysis and superlative analgesia, offers any benefits 
above current general anaesthetic techniques in cardiac surgery we need to 
explore whether TEA; provides protection to the myocardium (figure 1.) and 
other end-organs, and/ or promotes numerous additional benefits, including; 
early mobilisation and facilitation of fast-tracking. 
• stable haemodynamic profile, with 
* less intra- and post-operative hypertension 
* fewer pharmacological interventions 
• increased coronary perfusion pressure, owing to 
* decreased LV end-diastolic pressure 
* vasodilation of stenotic coronary segments 
• redistribution of myocardial blood flow, by 
* improved subendocardial perfusion 
* improved ischaemic collateral perfusion 
• reduced 
* duration of postischaemic myocardial stunning 
* myocardial infarct size 
• elevated arrhythmogenic threshold 
Figure 1. Potential cardiovascular benefits conferred by thoracic epidural analgesia (TEA). 
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• Myocardial protection : 
Perioperative ischaemic events occur in up to 3710 of patients, with a 
threefold increase in the incidence of P-MI in those who develop ischaemia 
[Slogoff & Keats, 1985]. The overall frequency of P-MI following cardiac 
surgery varies from 2.8io to 13.?io [Miller et. al, 1982; Gray et. al, 1982] and 
accounts for 40io of CABG-related deaths [Chaitman et. al, 1983]. 
Sympathetic stimulation promotes constriction of stenosed arteriosclerotic 
coronary arteries [Gould 1980; Brown et. al, 1985], a redistribution of blood 
flow from the endocardium to the epicardium and an increase in infarct size. 
These factors contribute to perioperative myocardial ischaemia and 
infarction (P-MI) that may complicate CABG surgery. 
Both coronary arteries and arterioles have innervated vasoconstrictor a-
receptors, and there is considerable evidence for a-adrenergic regulation of 
large coronary arteries and coronary resistance vessels [Feigl, 1982; Young 
et. al, 1986]. Blomberg et al. (1990) showed with arteriography that TEA 
increased the diameter of stenotic segments significantly without any 
change in non-stenotic segments or small vessel coronaries, thereby 
alleviating the theoretical fear that TEA could promote a coronary "steal 
syndrome". This withdrawal of the cardiac vasoconstrictor tone (Tl - T5) by 
TEA revealed a paradoxical resting vasoconstrictor tone, that may relate to 
the damaged endothelium in diseased epicardial arteries. It is interesting to 
note that Fujita et al. [1996] showed that TEA reduced the regional 
ischaemia induced by intracoronary injection of endothelin, in a dog model. 
Endothelin is a potent endothelium-dependent vasoconstrictor whose 
concentrations are known to rise during CPB. 
TEA has been shown to provide a stable haemodynamic profile and decreased 
left-ventricular end-diastolic pressure in animal models [Blomberg et. al, 
1990] and bradycardia without increasing LVEDP in humans [Blomberg et. al, 
1989]. Most clinical studies are in agreement that TEA provides greater 
haemodynamic stability (in particular a reduction in the incidence of 
perioperative hypertension) thereby requiring fewer pharmacological 
interventions to maintain coronary perfusion pressure in CABG surgery 
[Blomberg et. al, 1990; Liem et. al, 1992; Stenseth et. al, 1994]. TEA, 
furthermore, mediates a profound redistribution of myocardial blood flow 
in favour of the vulnerable subendocardial layers and decreases coronary 
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vascular resistance for collateral flow into ischaemic myocardium, as shown 
in dog models [Klassen et. al, 1980; Davis et. al, 1986]. 
All these factors improve the myocardial oxygen supply/demand balance 
(figure 2.) and experimental data exist showing a reduction in myocardial 
infarction size by TEA [Flatley et. al, 1985; Tsuchida et. al, 1984]. Supporting 
this, Rolf et al. [1996] demonstrated a beneficial effect of TEA on recovery 
of myocardial stunning in awake chronically instrumented dogs. The TEA was 
effective during the induction of brief regional myocardial ischaemia and 
resulted in a reduction of postischaemic myocardial dysfunction (stunning) as 
assessed by loss of wall-thickening fraction with pulsed Doppler epicardial 
probes. However, in the presence of propofol anaesthesia [Rolf et. al, 1996] 
TEA subsequently failed to reduce this duration of postischaemic myocardial 
dysfunction, with an unaltered blood-flow ratio between the subepicardial 
and subendocardial layers, which possibly relates to the vasodilatory 
properties of propofol. In a similar follow up study [Meissner et. al, 1998] 
sevoflurane-anaesthetised dogs showed similar recovery from myocardial 
stunning to that evidenced previously in awake dogs with TEA. This 
cardioprotective effect by sevoflurane was seen in the presence of, as well 
as in the absence of TEA and they therefore suggested that there was no 
synergistic protective effect (on the recovery of WTF) by TEA and 
sevoflurane anaesthesia, despite their known single protective effects. This 
may be due to both agents influencing sympathetic activity and influencing 
coronary vascular tone. Nevertheless, the non-additive effect of sevoflurane 
and TEA is in accordance with non-cardiac clinical studies in which TEA failed 
to improve cardiac outcome when used intra-operatively only [Baron et. al, 
1991; Bode et. al, 1996], but improved outcome when used in the 
postoperative period [Yeager et. al, 1987; Bradner et. al, 1998]. The main 
effect of TEA may therefore result from postoperative effects. 
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• vasodilation of stenotic coronary 
artery segments 
• 1" subendocardial blood flow 
• ~ LVEDP 
• ~ ischaemic collateral resistance 
• 1" perioperative 
haemodynamic stability 
• 1" arrhythmogenic 
threshold 
Figure 2. Cardiac sympatholysis (T1_4) promotes an improved myocardial oxygen 
supply/demand relationship. 
The autonomic nervous system plays a critical role in the central modulation 
of cardiac rhythm and may predispose the ischaemic myocardium to 
dysrhythmias [Euler et. al, 1985; Podrid et. al, 1990]. TEA has been shown to 
elevate the arrhythmogenic threshold to exogenously administered 
adrenaline in myocardium sensitised with halothane, an effect that may be 
mediated by unopposed parasympathetic activity [Kamibayashi et. al, 1995]. 
Similarly, Blomberg et al. [1988] showed a lower incidence of malignant 
ventricular arrhythmias during acute myocardial ischaemia in rats under 
TEA. In contrast, however, TEA instituted after the ischaemic episode did 
not reduce postinfarction ventricular dysrhythmia suggesting the epidural 
should be effective at the time of the ischaemic insult [Hogan et. al, 1997]. 
• Acute coronary syndromes : 
The role of high-TEA in the management of the patient presenting with an 
acute coronary syndrome (unstable angina, non-Q wave infarction) is under 
investigation. 
These patients stand to benefit from the following effects of TEA: good 
analgesia with cessation of myocardial ischaemia-induced cardiac 
sympathetic reflexes, and the beneficial effects on the major determinants 
of myocardial oxygen supply and demand. The sympathetic reflexes increase 
circulatory catecholamines, thereby triggering platelet accumulation in focal 
areas of diseased coronary arteries (Folt's phenomenon). Subsequent 
activation of these platelets releases serotonin which further precipitates 
coronary vasoconstriction [Staats et. al, 1997]. 
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Patients with unstable angina can benefit from the haemodynamic stability 
and epicardial vasodilation brought on by TEA sympatholysis, however, these 
patients have a reduction in myocardial oxygen supply rather than an 
increase in demand. This is attributed to the development of a sudden 
destabilising coronary event [Fuster et. al, 1992] due to either or a 
combination of clot formation, rupture of a fatty plaque, and intense 
coronary vasoconstriction. These processes are the endpoints of several 
activated pathophysiological cascades such as the clotting and inflammatory 
cascades, disturbed cardiac noradrenaline metabolism and the involvement of 
smooth muscle cells and fibroblast growth factors [Fuster et. al, 1992; 
Kleinman, 1997]. It is important to note that some of these cascades are not 
addressed by TEA and thus stand to benefit more from conventional 
therapies such as aspirin and heparin [Theroux et. al, 1988] or newer 
therapeutic modalities such as platelet glycoprotein IIb/IIIa receptor 
antagonists [Kereiakes, 1998]. 
The role and safety of what could be an optimal management strategy for 
patients with unstable angina on the medical care unit, that is, the 
combination of TEA (instituted prior to heparin administration) followed by 
chronic heparin infusion, or newer therapeutic modalities such as platelet 
glycoprotein IIb/IIIa receptor antagonists needs careful study by 
prospective randomised trials. 
• Thromboembolism : 
The risk of fatal pulmonary embolism is estimated at 5% following major 
surgery for individuals at high thrombotic risk [Clagett et. al, 1995; 
NCEPOD, 1996]. Meta-analysis has shown a reduced incidence in deep venous 
thrombosis when regional anaesthesia is used instead of general anaesthesia 
for emergency hip surgery, elective hip replacement, and other forms of 
non-cardiac surgery [Sorensen et. al, 1991]. 
Although the risk-profile of patients undergoing CABG surgery is high for 
deep venous thrombosis and fatal pulmonary embolism, this is offset by the 
use of preoperative aspirin therapy and perioperative anticoagulation. It thus 
remains to be shown that thromboembolism is pertinent in CABG surgery, 
whether TEA can reduce the incidence of deep vein thrombosis and 
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pulmonary embolism in this setting, and whether TEA blockade into the 
postoperative period is necessary. 
• Graft Patency : 
Current experience in peripheral vascular surgery suggests that patients 
requiring re-operation for graft thrombosis have higher circulating 
concentrations of noradrenaline [Parker et. al, 1995] and plasminogen 
activator inhibitor-! (marker of impaired fibrinolytic activity) [Rosenfeld et. 
al (PIRAT Study Group), 1993] in the perioperative period. 
It has been reported that regional anaesthesia results in a reduction in the 
incidence of graft thrombosis after peripheral vascular surgery [Tuman et. 
al, 1991; Christopherson et. al (PIRAT Study Group), 1993]. These studies 
have, however, been criticised for methodological limitations. Unlike the 
study by Yeager [1987], Tuman [1991] studied a homogeneous group of 
patients undergoing vascular surgery, however, the limitation of this study 
was that these patients were exposed to an inhomogeneous surgical stress 
(approximately half underwent aortic surgery and half underwent lower 
extremity arterial grafting). Additionally, non-equivalent modalities for 
postoperative pain control were used. Patients who were randomised to the 
epidural group received continuous postoperative epidural analgesia in 
contrast to the those randomised to the unsupplemented general anaesthesia 
group who received intramuscular or oral narcotics as needed from the 
surgical ward nurses with no special monitoring of the efficacy of this 
modality. The differences reported by this group may therefore, be related 
to the fact that the patients randomised to unsupplemented general 
anaesthesia received systematically inferior postoperative analgesia. In 
contrast, Christopherson studied a homogeneous group of patients 
undergoing a similar homogeneous surgical stress, namely, lower extremity 
vascular surgery. It may be argued that the limitations of this study was 
that the surgical procedure was not stressful enough and that they were 
unable to separate the differences due to intraoperative techniques and 
postoperative techniques because all patients who received epidural 
anaesthesia received epidural analgesia, and all who received general 
anaesthesia received intravenous patient controlled analgesia. It may be that 
the type of postoperative analgesia used may influence the frequency of 
thrombotic complications and graft occlusion. 
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In contrast other groups [Cook et. al, 1986; Pierce et. al, 1997] have failed to 
show any benefit of regional anaesthesia (spinal, and spinal or epidural, 
respectively) during or after surgery. Clearly, further prospective 
randomised studies are required to provide an answer to this issue. 
With respect to cardiac surgery, the Society of Thoracic Surgeons National 
Database reveals that 15'Yo of patients underwent reoperative surgery 
related to progression of disease in native vessels or atherosclerotic 
occlusion in previously placed vein grafts in the year 1995/96. Graft 
occlusion within the first month and 10 years postoperatively is estimated at 
lO'Yo and 50% of vein grafts, respectively. 
Factors promoting early phase graft occlusion include; surgical technique 
exposure of the sub-endothelial tissues, surgical stress-response promoting 
a hypercoagulable postoperative state, and increased levels of 
catecholamines which may promote vasoconstriction with poor distal run off. 
The use of the internal mammary artery to the left anterior descending 
coronary artery is associated with patency rates greater than 90'Yo. 
However, the use of multiple arterial grafts may be associated with an 
increase in perioperative morbidity that is related to the increased 
reactivity of these arterial conduits, which in the presence of increased 
circulating catecholamines may result in graft spasm and secondary 
myocardial ischaemia. If arterial revascularisation is superior to vein grafts, 
then the role of TEA in the prevention of graft spasm during complete 
arterial coronary revascularisation needs to be studied. Furthermore, the 
suggestion that regional anaesthesia may reduce the incidence of graft 
thrombosis after peripheral vascular surgery [Tuman et. al, 1991; 
Christopherson et. al (PIRAT Study Group), 1993] it is therefore not too 
inconceivable that TEA may reduce this early phase of coronary bypass graft 
occlusion, thereby reducing the need for reoperative CABG surgery. These 
possible benefits by TEA, however, still need to be explored. 
• Pulmonary effects : 
Whether the frequency and severity of postoperative pulmonary 
complications can be favourably influenced with TEA is controversial [Yeager 
et. al, 1987; Pierce et. al, 1997]. It is suggested that TEA may diminish 
ventilation through peripheral neural blockade or the systemic effect of 
local anaesthetics. The provision of superb analgesia, however, more 
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importantly allows earlier mobilisation and more effective physiotherapy. 
Recently, Sakura et al. [1996] investigating the effects of lumbar and 
thoracic epidural anaesthesia on the ventilatory response to hypercapnia and 
hypoxia in elderly patients, found that lumbar epidural anaesthesia had no 
significant effect on resting ventilation, whereas thoracic epidural block 
caused a significant decrease in minute ventilation (13%) and tidal volume 
(14'Yo). The ventilatory response to hypercapnia was significantly increased 
after lumbar epidural anesthesia, but no change was observed after thoracic 
epidural anaesthesia. The slope of the hypoxic response curve did not show 
any change in either group, but minute ventilation at a Sp02 of 90'Yo 
significantly increased after lumbar epidural anaesthesia. 
It can therefore be assumed that neither lumbar nor thoracic epidural 
anesthesia per se impairs the ventilatory response to hypercapnia and 
hypoxia, despite slight impairment in resting ventilation by thoracic epidural 
anesthesia, in elderly patients. 
Stenseth et al. [1996] 53 , comparing a low-dose opioid TEA group to a high-
dose opioid general anaesthesia group, showed similar reductions in forced 
vital capacity and forced expiratory volume in 1 second (FEV1.o) and 
increased pulmonary shunt and alveolar-arterial oxygen gradients between 
the groups in the early postoperative period. However, higher FEV1 and PEFR 
on days 2 and 3 were seen in the TEA group than in the control group. 
Pulmonary shunt and alveolar-arterial oxygen difference increased similarly 
in both groups, whereas oxygen delivery and mixed venous oxygen saturation 
were higher in the epidural group. This suggests that TEA yields a slight, but 
significant, improvement in pulmonary function, most likely due to a more 
profound postoperative analgesia. 
• Fast tracking: 
Financial and clinical considerations have prompted many anaesthetists to 
advocate early extubation after uncomplicated revascularisation instead of 
traditional prolonged respiratory support. Studies by Joachimsson et al. 
[1989] and Liem et al. [1992], comparing the influence of a general 
anaesthetic technique using intravenous opioids with a combined regional and 
general anaesthetic technique, showed that TEA provides superlative 
analgesia, obviating the need for opioids and reducing the duration of 
mechanical ventilation, facilitating early extubation with improved 
respiratory function and enhanced control of blood pressure in the 
postoperative period. Improvement of these factors could therefore 
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potentially facilitate fast-tracking, with earlier discharge from intensive 
therapy and surgical wards. 
Newer pharmacological agents, including the ultrashort-acting opioids like 
remifentanil, also facilitate stress-response attenuation and allow almost 
immediate awakening, extubation and facilitation of fast-tracking. The draw 
back of these agents, however, is the lack of postoperative analgesia, 
requiring the administration of other opioids such as morphine. 
A randomised prospective trial comparing either TEA or remifentanil or in 
combination intraoperatively, followed by postoperative TEA, would be 
meaningful, as this may be the most effective way of providing perioperative 
analgesia, stress-response attenuation, and the ability to fast-track a 
patient through the intensive therapy unit, with early mobilisation and 
discharge from hospital. 
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C. Potential adverse effects 
Neurologic sequelae: 
The incidence of neurologic complications following TEA remains 
controversial. A major concern of TEA is the possibility of blood vessel 
damage during insertion of the epidural needle or during the insertion or 
removal of the epidural catheter resulting in the development of an epidural 
haematoma, with compression of the spinal cord. Paradoxically, safe 
catheterisation has been performed on patients with known coagulopathies 
[Dahlgren Net. al, 1995], however, it is argued that there is increased risk in 
patients with coagulation disorders and those treated with anti-coagulants 
[Kane, 1981; Dickman et. al, 1990; Schmidt et. al, 1992]. 
In the setting of cardiac surgery the patient, often on aspirin, is fully 
heparinised to facilitate CPB, and this should theoretically increase the 
incidence of this adverse event. Although rare, it should be remembered 
that epidural haematoma, most commonly found in the thoracic spine, can 
also occur spontaneously, without trauma. 
In a prospective trial, Giebler et. al [1997] studied the incidence of 
neurologic sequelae in 2,059 prospective and 2,126 retrospective patients 
undergoing TEA for abdominothoracic surgery. The following complications 
occurred; failed block (1.1%), dural puncture (0.7% - with an interesting 
observation that incidence increased proportional to the usage of more 
caudal sites), and postoperative radicular type pain (0.2% - all were 
responsive to catheter removal), and peripheral nerve lesions (0.6 io - most of 
which were attributed to patient positioning). No evidence of permanent 
sensory or motor defects were attributable to epidural catheterisation, and 
no evidence of epidural haematoma was seen. In this article Giebler et. al 
[1997] calculated a 0.07io maximum risk at 95% confidence for permanent 
neural lesions after TEA. 
Reviewing case reports of spinal haematomas associated with both epidural 
and spinal regional anaesthetic techniques from 1906 to 1994 Vandermuelen 
et. al [1994] identified a total of only 61 cases. It was noted that 68io (n = 
42) of these were associated with impaired coagulation. In most instances (n 
= 30) some form of heparin therapy was in use. The remaining 12 patients 
had a variety of conditions including thrombocytopenia, chronic alcohol 
abuse, chronic renal failure, or were receiving aspirin or other antiplatelet 
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medication at the time of bleeding. Overall, in 87% of these cases, there 
were either puncture difficulties or a coagulation disorder. Vandermuelen et. 
al [1994], estimated the incidence of haematoma formation at 1: 150,000 
after epidural catheterisation. 
Similarly, Wulf [1996] in a comprehensive search (from 1966 to 1995) found 
only 51 case reports of spinal haematomas associated with epidural 
anaesthesia. Most cases were associated with catheter insertion and 4210 of 
these were graded as difficult or traumatic. Coagulopathies or anticoagulant 
therapy were the predominant risk factors identified. In comparison, low-
dose heparin thromboprophylaxis or non-steroidal anti-inflammatory 
(NSAID) treatment was rarely associated with spinal bleeding complications. 
Tryba et. a/[1997] in a similar review of case reports describing spontaneous 
epidural haematomas over a 30-year period found 199 cases, of which 20% 
were associated with anticoagulation therapy. 
Bleeding can follow epidural catheter insertion, manipulation [Usubiaga, 
1975], migration or removal [Tekkok et. al, 1991, Onishchuk et. al, 1992, 
Skilton et. al, 1998]. It is important to note that Vandermuelen et. al [1994] 
found that spinal bleeding occurred immediately after removal of the 
epidural catheter in 15 out of 32 cases that were reviewed. 11 of these 
catheters were removed when heparin levels were therapeutic or within 2-
hours of stopping heparinisation. 
Unfractionated heparin is rapidly cleared from plasma with an average half-
life of 1-2 hours. This half-life, however, is dose dependent and may be 
significantly prolonged at higher doses (56 min at 100 iu/kg cf. 152 min at 
400 iu/kg) [McEnvoy, 1997]. Compared to the immediate anticoagulant 
effects with an intravenous bolus of heparin, peak plasma level is only 
reached at 2 to 4- hours following subcutaneous administration. Wildsmith 
and McClure et. al [1991] suggest that a 4- to 6- hour interval is safe 
following the administration of subcutaneous heparin before instituting a 
block, and that intravenous heparin should be stopped for 1 to 2- hours to 
allow safe catheter removal. However, note that this latter time interval 
represents only one half-life and it would seem more appropriate to 
recommend that a minimum of two half-lives, or 4-hours pass before epidural 
catheter removal [Skilton et. al, 1998]. 
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Enoxaparin, a low-molecular-weight heparin (LM WH), was approved for 
general use in May 1993. It is interesting to note that since the approval the 
United States Food and Drug Administration (FDA) have received reports of 
nearly 40 patients in the United States who had spinal / epidural haematoma, 
following the concurrent use of enoxaparin and neuraxial anaesthesia 
between May 1993 and April 1998 [Wysowski et. al, 1998, Horlocker et. al, 
1998]. In 6 of these patients, bleeding or haematoma developed after 
removal of the catheter. 
In comparison, only 11 cases have been reported since 1987 in the European 
literature, where the recommended dosage regimen is lower (20 to 40 mg, 
once daily in Europe vs. 60 mg daily [30 mg twice daily] in the USA), and 
where published guidelines for the timing of LM WH dosing in relationship to 
neuraxial instrumentation are in place i.e. 8-12 h prior to neuraxial 
instrumentation, 8-12 h delay from instrumentation to the next dose, and 8-
12 h following the last dose before the epidural catheter is removed [Tryba 
et. al, 1997]. This represents two half-lives and the equivalent for standard 
heparin, as mentioned above, would therefore be a time interval of 2-4 h, 
allowing for a true trough in anticoagulant activity. The plasma half-life of 
LMWH is 2-4 times that of standard heparin and increases in patients with 
renal failure. Peak anti-Xa activity occurs 3-4 h after a subcutaneous 
injection of LMWH, and 12- h anti-Xa levels are approximately 50% of peak 
levels [Hirsh et. al, 1994]. It is, furthermore, important to remember that 
the residual anticoagulant effect of LM WH is only partially reversed by 
protamine. 
Recent calculations based on the knowledge of the number of doses of 
LM WH distributed, estimated the frequency of spinal haematoma between 1: 
1,000 and 1: 10,000 neuraxial blocks when used concurrently with LM WH 
[Horlocker et. al, 1997]. This incidence for spinal haematoma is more 
frequent than that of previous assessments, which have estimated the 
probability of significant spinal bleeding after regional anaesthesia to be 
approximately 1: 200,000. (1: 190,000 - Wulf; 1: 150,000 - Giebler ). 
However, because this represents the upper 95% confidence interval, the 
actual incidence of spinal haematoma should be much lower, approximately 1: 
1,000,000 [Tryba, 1993]. 
Aspirin therapy is common in patients with IHD, and the evidence for safety 
of epidurals in patients on aspirin is increasing [Horlocker et. al, 1990; De 
Swiet et. al (CLASP), 1992; Orlikowski et. al, 1992; Beilin et. al, 1997]. 
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In a prospective study, to determine the risk of haemorrhagic complications 
associated with regional anaesthesia, Horlocker et. al reviewed 924 patients 
given spinal or epidural anaesthesia for orthopaedic procedures. 
Preoperative anti platelet medications were taken by 39% of patients (21 % on 
aspirin) and it was found that this did not increase the incidence of minor 
haemorrhagic complications (defined as blood noted during needle or 
catheter placement) - which was noted to occur in 22% of patients. There 
were no documented major haemorrhagic complications (spinal haematoma) in 
this study. 
Olikowski et. al [1992] used thromboelastography (TEG) to assess all phases 
of coagulation in a group of healthy volunteers and in a group of pregnant 
patients after aspirin therapy, showed that TEG measured indices were 
unaltered after aspirin therapy, suggesting a functioning coagulation system 
despite prolonged bleeding time in both groups. The criticism of this study, 
however, is that the TEG does not evaluate interaction at platelet-
endothelial level. 
The development of a spinal haematoma is a catastrophic complication. Using 
an extensive Medline search, the author was unable to find any case reports 
of spinal haematoma associated with TEA for cardiac surgery. Undoubtedly 
there are cases and the author is aware of at least 3 unpublished cases of 
paraplegia (UK and USA, 1997) related to neuraxial techniques for cardiac 
surgery. A number of important issues that need addressing arise here; 
Firstly, the importance of reporting all cases of epidural haematoma in the 
medical literature, thereby allowing a true assessment of the associated 
risks, rather than by hear-say. 
Secondly, these cases of haematoma are believed to have had their epidural 
catheter inserted using a more liberal technique, that is, immediately prior 
to surgery, ensuring at least 60 minutes lapse from the time of 
instrumentation to the time of full heparinisation. These findings are of 
extreme concern and we would recommend a more conservative approach be 
used, that is, epidural catheter insertion at least 2 heparin half-lives (4-
hours) [Skilton et. al, 1998] or preferably 12- hours (evening prior to) prior 
to surgery. Thirdly, guidelines should be in place and strictly adhered to 
during neuraxial instrumentation. The guidelines suggested for the use of 
TEA in cardiac surgery (figure 3.) [Vandermeulen et. al, 1994; Rolf et. al, 
1997] are sound, if conservative [Liem et. al, 1992; Stenseth et. al, 1994] as 
several groups [Moore et. al, 1995; Tuffrey et. al, 1997] place the epidural 
catheter immediately prior to surgery, ensuring at least 60 minutes lapse 
from the time of instrumentation to the time of full heparinisation 
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[Vandermeulen et. al, 1994], with postponement of surgery if a bloody tap 
occurs. Fourthly, all patients undergoing neuraxial block require repeated 
neurological evaluation to facilitate early diagnosis of spinal haematoma. 
Pre-operative Guidelines 
1. Discontinue oral anticoagulants 
• 3 days before epidural catheter insertion 
• check coagulation parameters immediately prior to 
instrumentation 
2. Discontinue aspirin therapy 
• preferably up to 10 days before instrumentation 
Intra-operative Guidelines 
1. Allow time between epidural catheter placement and heparinisation 
• 12 hours is currently recommended as safe. 
• the epidural catheter is best placed the evening before 
surgery 
2. Intraoperative activated clotting time 
• should not exceed 600 - 700 s. 
3. Ensure unobstructed venous drainage during CPB to prevent 
epidural venous bleeding 
Post-operative Guidelines 
1. Restore prebypass coagulation parameters following CPB 
• by protamine administration 
• appropriate treatment of other clotting disorders (e.g. 
thrombocytopenia) 
2. Before epidural catheter removal 
• ensure coagulation parameters are within normal ranges 
Figure 3. Guidelines recommended for the safe practice of thoracic epidural anesthesia in 
cardiac surgery [Rolf et. al, 1996]. 
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It is important to emphasise that failed or abandoned neuraxial 
instrumentation should also be followed up by repeated neurological 
evaluation in the postoperative period. This is highlighted by a recent case of 
paraplegia in a patient scheduled for thoracotomy at the authors institution. 
Neuraxial instrumentation failed, was abandoned, and the elected surgical 
procedure was successfully completed under general anaesthesia. However, 
the failure to implement postoperative neurological evaluation resulted in a 
missed diagnosis of spinal haematoma and the subsequent dire consequence 
of irreversible paraplegia developing in the postoperative period. 
Although certain groups of patients undergoing cardiac surgery may benefit 
more from the use of TEA e.g. left ventricular hypertrophy (secondary to 
aortic valve disease etc.), the use of TEA in patients not suitable for fast 
tracking is more controversial. This relates to the immediate need to 
investigate patients with computerised tomography or magnetic resonance 
imaging if a motor deficit out of proportion to the expected block is 
detected, with emergent neurosurgical decompression within 6 to 12- hours, 
in an attempt to preserve neurologic function [Stephanov et. al, 1982; 
Vandermeulen et. al, 1994;]. This also highlights the importance of having a 
neurosurgical referral system in place. 
In an attempt to monitor for spinal haematoma formation in patients with 
TEA catheters in situ, who require prolonged ventilation and sedation in the 
intensive therapy unit following unexpected complicated surgery, it may be 
warranted to explore the role of evoked potential monitoring or pressure 
monitoring of the epidural space. 
Other potential complications 
Other potential complications of neuraxial blockade include severe 
cardiovascular events, respiratory depression / apnoea, incomplete block, 
malpositioned catheters, dural puncture, dural abscess, and site infection. 
Well documented series include the American Society of Anaesthesiologists 
Closed Claim Study [1988] report of 14 cases of sudden cardiac arrest 
during spinal anaesthesia in healthy patients undergoing minor surgical 
procedures [Caplan et. al, 1988], and several cases of sudden cardiac arrest 
during lumbar epidural anaesthesia [Fredericks et. al, 1988; Gild et. al, 1990]. 
Case reports of severe bradycardia and asystole during TEA catheter 
insertion [Sprung et. al, 1998] and similarly asystole after segmental TEA in 
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a healthy patient following breast surgery [Chan et. al, 1997] have been 
reported. 
More commonly, the risk of a more extensive epidural blockade causing 
marked systemic hypotension with a subsequent reduction in coronary 
perfusion pressure, and onset of myocardial ischaemia exists. The 
maintenance of coronary perfusion pressure often requires early prebypass 
administration of pharmacological vasoconstrictors. 
Sympathetic blockade during TEA, may exceed the sensory block in the 
caudal direction, however, with lumbar epidural sympathetic blockade does 
not exceed the sensory block in the cephalad direction [Hopf et. al, 1990]. 
Leaving the parasympathetic tone unopposed, may result in a marked 
reduction in cardioacceleration (sympathetic activity) in response to a 
decrease in blood pressure while preserving the cardiac slowing 
(parasympathetic activity) in response to increased blood pressure [Goertz 
et. al, 1992]. Chan et al. [1997] warn that in the presence cardiac 
sympathetic fibre inhibition and enhanced vagal tone, a decrease in central 
venous return can be an important factor in triggering cardiac arrest during 
epidural anaesthesia. Postoperative bleeding is often severe following cardiac 
surgery, and the responsiveness of heart rate to hypovolaemia in patients 
with TEA is reduced, the hypovolemia may therefore go unnoticed, and risk 
triggering cardiac arrest. 
Measuring sympathetic nerve activity directly in cardiac and renal nerves, it 
is suggested that sympathetic nerve activity is enhanced in the 
unanaesthetised segments of cats undergoing thoracic or lumbar epidural 
anaesthesia [Taniguchi et. al, 1997]. This was, however, associated with a 
significant decrease in mean arterial pressure and heart rate. On further 
study it was shown that with the disruption of the carotid sinus and 
vagoaortic nerves, enhanced sympathetic nerve activity in the 
unanaesthetised segments was not seen, concluding that the enhanced 
sympathetic nerve activity in the unanaesthetised segments was produced by 
the baroreceptor reflex response to anaesthesia-induced hypotension. The 
effect of the baroreceptor reflex on sympathetic nerve activity has been 
shown to be quantitatively non-uniform for different organs; for example, 
the baroreceptor-dependent component of sympathetic nerve activity to the 
heart or kidney exceeds 95'Yo, where as that to the skin is only 5%. 
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This suggests that patients with TEA who become hypovolaemic will have 
compensatory excitation of the renal sympathetic nerves and renal 
vasoconstriction. Similar reductions in splanchnic bed perfusion are also 
possible, and studies using gastric tonometry are awaited. These data 
emphasise the importance of maintaining an adequate perfusion pressure in 
the presence of TEA, in an attempt to avoid the compensatory baroreceptor 
reflex-induced sympathetic nerve hyperactivity in the unanaesthetised 
segments. 
It thus follows that catheter position is an important variable if this 
technique is to be successful. For example if the catheter is malpositioned 
and the cardiac nerves (Tl-4) are left unblocked then compensatory 
baroreceptor reflex-induced sympathetic nerve hyperactivity will have 
detrimental effects, promoting constriction of stenosed arteriosclerotic 
coronary arteries [Gould 1980; Brown et. al, 1985], redistribution of blood 
flow from the endocardium to the epicardium and an increase in infarct size. 
These factors may all contribute to perioperative myocardial ischaemia and 
result in perioperative myocardial infarction (P-MI) and complicate CABG 
surgery. 
Catheters are positioned by various authors in a wide range of positions 
ranging from vertebral interspace C7 to T6. Radiographs of radio-opaque 
epidural catheters inserted for patients undergoing thoracic surgery showed 
that despite the positioning of the epidural needle orifice in the cephalad 
direction and advancement of the catheter 3 to 4 cm in the same direction, 
only 39 i'o of the catheters were positioned cephalad compared with the 
insertion level. To study the migration of these catheters, chest radiography 
was performed daily for 3 days after operation. The catheter tip position 
remained unchanged in all patients operated upon in the supine position. In 
those operated on in the lateral position, the catheter tip retracted from 
day 1 to day 2 by an average of 0.69 cm (SD, 1.08; p < 0.05), and from day 2 
to day 3 by an average of 0.35 cm (SD, 0.67; p < 0.05) [Hendriks et. al, 1997]. 
Clearly, every attempt should be made for optimal catheter positioning, 
thereby ensuring blockade of cardiac sympathetic innervation. 
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D. Summary 
It has been suggested that thoracic epidural anaesthesia and analgesia 
(TEA) should be considered as a therapeutic option for patients with 
symptomatic end-stage multivessel disease, not amenable to 
revascularisation [Blomberg, 1994]. 
Patients with unstable angina may stand to benefit more from anticoagulation 
with heparin and aspirin or glycoprotein IIb / IIIa receptor antagonists than 
from TEA, in an attempt to arrest various pathophysiological cascades. The 
optimal benefit may, however, be gained by combining TEA and 
anticoagulation and randomised clinical trials are awaited. 
Experimental data suggests that TEA may have anti-ischaemic effects, and 
clinical data suggests that the supplemental use of TEA with general 
anaesthesia results in improved hemodynamic stability, perioperative stress-
response attenuation, improved postoperative analgesia and facilitates 'fast-
tracking' in the setting of cardiac surgery. 
The risk-benefit ratio of TEA in the setting of cardiac surgery, however, 
needs to be firmly established before it is routinely used - especially in view 
of the potential risk of epidural haematoma formation associated with full 
intraoperative heparinisation. TEA is still uncommon during CABG surgery 
and well designed trials with adequate numbers of patients to investigate the 
ability of TEA to reduce the morbidity and mortality of patients undergoing 
cardiac surgery are still needed [Chaney et. al , 1997]. 
The true benefit of TEA may lie in ; 
1) the reduction of adverse perioperative cardiac outcome. This is 
supported by experimental data, showing that TEA may have anti-
ischaemic effects with a resultant reduction in myocardial ischaemia, 
stunning and infarction size. 
2) the reduction in early graft occlusion with a subsequent reduction in the 
need for re-operation. This is supported by clinical data suggesting that 
TEA facilitates coronary vasodilation, as well as clinical data suggesting 
that regional anaesthetic techniques reduce the peripheral vascular 
surgery graft occlusion incidence. 
If this can be proved, then these data will provide for a favourable risk-
benefit ratio, justifying the use of this analgesic technique in cardiac 
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surgery. Recent trials include a retrospective trial by Tuffrey et. al, [1997] 
and a prospective trial by Sanchez et. al [1998], however, to the authors 
knowledge no clinical studies have addressed these endpoints. 
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E. Hypothesis 
Based on this background we designed a pilot study using primary and 
secondary endpoints (see below) to test the hypothesis that thoracic 
epidural analgesia (TEA) (through stress response attenuation, cardiac 
sympatholysis and peri-operative analgesia) provides a more favourable 
perioperative physiological milieu than conventional opioid-based general 
anaesthesia for coronary artery bypass grafting (CABG) surgery. 
Furthermore, the provision of a favourable perioperative physiological milieu 
may result in a reduction in the incidence of perioperative ischaemia and a 
reduction in the incidence of early graft occlusion, with improved immediate 
perioperative as well as long-term outcome (including a reduction in the 
incidence of re-operative procedures) of patients undergoing CABG surgery. 
Thereby, despite the theoretical increased risk of spinal haematoma, the use 
of TEA in cardiac surgery would be associated with a favourable risk / 
benefit profile. 
We tested our hypothesis by comparing 2 anaesthetic techniques: namely, 
the use of TEA as an adjunct to an opioid-free, general anaesthetic 
technique, vs. an opioid-based, balanced, general anaesthetic technique. This 
was studied in patients scheduled for elective CABG surgery at Harefield 
Hospital, Harefield & Royal Brompton NHS Trust, an independent 
cardiothoracic institution in the United Kingdom. 
The following endpoints were used in this study to evaluate this hypothesis; 
1. sympatholysis: 
• haemodynamic stability 
• thermodilution derived haemodynamic indices 
• preservation of cardiac performance 
• myocardial ischaemia: 
* Holter monitoring (ST-segment monitoring, arrhythmias) 
* ischaemic injury markers - creatine kinase (CK), cardiac 
troponin-I (cTn-I) 
2. stress-response attenuation 
• catecholamines 
• cortisol 
• hypercoagulability indices - plasminogen activator inhibitor-1 
• endothelin-1,2 
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3. analgesia 
• visual analog pain scoring (VAS) 
• facilitation of fast-track recovery 
* respiratory function (Pa02/Fi02), 
* mini-mental test 
* time to extubation 
* time to discharge from ITU and discharge from hospital 
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III. GENERAL METHODOLOGY 
A. Patients 
Regional ethical committee (Hillingdon Health Authority, Middlesex, UK: 
Ethics Committee Submission 693) approval was obtained for this 
prospective study. Twenty consenting patients in the New York Heart 
Association (NYHA) functional class II or III, with preoperative ejection 
fractions greater than 45 'Yo (as determined by ventriculography) scheduled 
for routine myocardial revascularisation were studied. They were 
randomised to receive either; 
• a cervico-thoracic epidural (C7 - Tl), as an adjunct to an opioid-free 
general anaesthetic technique {TEA group; n = 10) 
or 
• a balanced, opioid-based general anaesthetic technique (propofol-fentanyl-
isoflurane), as routinely used in our institution {GA group; n = 10). 
Patients were randomised by envelope. Once randomisation had occurred, 
however, there was no further blinding and each patient was managed in an in 
such a manner as to maintain haemodynamic stability in the perioperative 
setting. Maintained blinding of the investigators would be ideal, and this 
could be done by placement of an epidural catheter in all patients. However, 
with the current controversy and relative risk of a spinal haematoma - we 
regarded it as unethical to position an epidural catheter and not use it 
appropriately in the general anaesthetic (control) group. 
Patients on anticoagulation therapy (e.g. warfarin) were excluded from this 
study. Aspirin was discontinued preoperatively (range: 2 days to 1 week) by 
all patients. A preoperative coagulation screen (partial thromboplastin time & 
prothrombin time) was done and found to be normal in all patients. 
B. Conduct of anaesthesia and surgery. 
In all patients pre-operative anti-angina! therapy was continued until the 
morning of surgery. Temazepam (10 - 20 mg) and ranitidine (150 mg) was 
administered orally as premedication 90 minutes prior to surgery. All 
RIEDEL B.J.C.J. 30 
patients underwent anaesthesia and surgery by the same medical 
practitioners, in accordance with the same anaesthetic and operative 
protocols. 
1. Thoracic epidural analgesic technique: 
Patients in the TEA group had an epidural catheter sited in theatre the 
evening prior to surgery. Venous access was obtained prior to the procedure 
and the patient monitored throughout the procedure with pulse-oximetry 
and non-invasive blood pressure measurements. 
Using the sitting position, a 16-G Touhey needle, with the bevel directed 
cephalad, was sited into the epidural space at the C7 /Tl or Tl/2 interspace 
using a mid line approach. On localisation of the epidural space, with the 
'hanging-drop' technique, the epidural catheter was then advanced 4 - 5 cm 
through the needle. Correct placement was then tested with a 3-ml 1% 
lignocaine test dose. Once the epidural was sited the patients were returned 
to the ward and allowed to mobilise fully. Ward nursing staff were 
instructed to do 4 hourly epidural observations. 
This procedure was abandoned in one patient only, following three 
unsuccessful attempts to localise the epidural space. 
In theatre, the following morning, the epidural catheter was aspirated for 
cerebrospinal fluid or blood to check for catheter migration and correct 
placement was tested again with a 3-ml 1 % lignocaine test dose. 
Prior to the induction of general anaesthesia, the regional blockade was 
established using 0.125 ml.kg-1 bolus of 0.5t'o bupivicaine (with 2 µg.m1-1 
fentanyl). The spread of blockade was evaluated 10-15 minutes later using 
onset of paraesthesia in the finger tips (C7 - Tl dermatomes) or reduced 
ability to discriminate temperature differences in upper thoracic 
dermatomes as signs of blockade onset. Adequate blockade was maintained 
with an infusion of O.lt'o bupivicaine (with 2 µg.m1-1 fentanyl) at a rate of 5 - 8 
ml.h-1 (0.1 ml.kg-1.h-1). 
Radial artery and peripheral venous catheters were inserted under local 
anaesthesia. General anaesthesia was then induced with propofol (1 - 2 
mg.kg-1) and neuromuscular blockade obtained by pancuronium (0.15 mg.kg-1) . 
Following the induction of general anaesthesia and oral intubation, central 
venous and pulmonary artery catheters were inserted using the right internal 
jugular vein. 
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The lungs were ventilated with a nitrous oxide / oxygen mixture prior to 
aortic cannulation, followed by a air / oxygen mixture after cannulation for 
CPB. Propofol (3 mg.kg-1.h-1) was infused throughout the entire procedure and 
into the ITU period until the patient was considered ready for extubation. 
Isoflurane was added to supplement the propofol infusion and was allowed as 
escape therapy (0.5 - 1.5%) to control hypertensive episodes, otherwise both 
groups were ventilated with 0.5 MAC isoflurane. No data was collected on 
the mean isoflurane partial pressures. Midazolam (0.1 mg.kg-1) was 
administered at the commencement of CPB in both groups of patients. 
Postoperative analgesic management for all TEA patients consisted of a 
single dose of diclofenac (100 mg rectally) and an epidural infusion of 0.1 % 
bupivicaine (with 2 µg.m1-1 fentanyl) at a rate of 0.1 ml.kg-1.h-1, which was 
maintained until 72-hours postoperatively. Once the patient was extubated 
and tolerating oral fluids, analgesia was supplemented as required on request 
by the patient, using oral analgesic formulations containing paracetamol and 
either dihydrocodeine tartrate (Co-dydramol®) or dextro-propoxyphene 
hydrochloride ( Co-proxamol® ). 
2. General anaesthetic technique: 
Radial artery and peripheral venous catheters were inserted under local 
anaesthesia. General anaesthesia was then induced with propofol (1 - 2 
mg.kg-1). Fentanyl (low - intermediate dose; 10 - 15 µg.kg-1) was titrated from 
induction to sternotomy. Neuromuscular blockade was obtained by 
pancuronium (0.15 mg.kg-1). Following the induction of general anaesthesia and 
oral intubation, central venous and pulmonary artery catheters were inserted 
using the right internal jugular vein. 
The lungs were ventilated with a nitrous oxide / oxygen mixture prior to 
aortic cannulation, followed by a air / oxygen mixture after cannulation for 
CPB. Propofol (3 mg.kg-1.h-1) was infused throughout the entire procedure and 
into the ITU period until the patient was considered ready for extubation. 
Isoflurane was added to supplement the propofol infusion and was allowed as 
escape therapy (0.5 - 1.5'Yo) to control hypertensive episodes, otherwise both 
groups were ventilated with 0.5 MAC isoflurane. No data was collected on 
the mean isoflurane partial pressures. Midazolam (0.1 mg.kg-1) was 
administered at the commencement of CPB in both groups of patients. 
RIEDEL B.J.C.J. 32 
Postoperative analgesic management for all GA patients consisted of a single 
dose of diclofenac (100 mg rectally) and a continuous intravenous morphine 
infusion (1-3 ml.h-1) that was commenced during CPB. Once the patient was 
extubated and tolerating oral fluids, analgesia was supplemented as required 
on request by the patient, using oral analgesic formulations containing 
paracetamol and either dihydrocodeine tartrate (Co-dydramol®) or dextro-
propoxyphene hydrochloride ( Co-proxamol® ). 
C. Cardiopulmonary bypass and myocardial preservation: 
During surgery, all patients received porcine heparin (300 IU.kg-1) for 
systemic anticoagulation to facilitate cardiopulmonary bypass (CPB). 
Additional heparin boluses were given to maintain an activated coagulation 
time (ACT) > 480 seconds. CPB was established with drainage via atrial 
cannulation and with return via an aortic cannula. The extracorporeal circuit, 
consisting of a cardiotomy reservoir, a rollerpump (Cobe Stockert; Stockert 
Instrument, Rungis, France) and a membrane oxygenator (Sorin 
Laboratories, Mirandola, Italy) providing nonpulsatile bypass (bypass flow: 
2.4 L.min-1.m-2). The circuit was primed with 1,500 ml of lactated Hartmans 
solution, and mannitol (20 io : 1 ml.kg-1). 
Myocardial preservation strategy utilised moderate systemic hypothermia 
(32-34 °C, nasopharyngeal temperature), cold (4 °C) crystalloid cardioplegia 
(St Thomas I), delivered anterogradely via the aortic root and topical cooling 
(ice-slush) of the heart during the period of aortic cross-clamping. 
Cardioplegia was repeated every 30 minutes or earlier if electrical activity 
was observed on the ECG. 
Once revascularisation was completed, the patient was weaned from bypass, 
heparin neutralised by protamine sulphate, bleeding controlled, the sternum 
closed, and the patient taken to ITU for recovery. 
D. Experimental protocol 
The study-design aimed to investigate whether TEA provided a more 
favourable perioperative physiological milieu than the GA technique, through 
sympatholysis, stress response attenuation and improved analgesia. 
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Measurements, included a full haemodynamic profile (pressures, and 
thermodilution technique), Holter ECG analysis, and collection of plasma / 
serum samples for analysis of catecholamines (noradrenaline & adrenaline), 
creatine kinase (CK), creatine kinase-MB isoenzyme (CK-MB), cortisol, 
cardiac troponin-I (cTn-I), endothelin and plasminogen activator-inhibitor-1 
(PAI-1). 
A full haemodynamic profile was obtained at the following time points: 
• baseline - after induction of anaesthesia 
• intraoperative - following pericardiotomy, prior to cannulation 
• postoperative - 1-, 3-, 6-, 12, 18-hours following CPB cessation 
Holter ECG monitoring was commenced at least 6- to 12-hours prior to CPB 
for baseline (pre-operative) analysis, and continued for 72-hours following 
the cessation of CPB for post-operative analysis. 
Plasma/ serum samples were collected at the following time points: 
• baseline - prior to induction of anaesthesia 
• intraoperative - 10- minutes after initiation of CPB 
• postoperative 
10- minutes after aortic cross-clamp removal 
(plasma catecholamines only) 
- 1-, 3-, 6-, 12-, 18-, 24-, 72-hours following 
cessation of CPB, and Day 5. 
Samples were collected into lithium-heparin tubes (noradrenaline, adrenaline, 
CK, CK-MB isoenzyme), clotting tubes (cortisol, cTn-I), and strong acidic 
citrate tubes (PAI-1), centrifuged (3 500 rpm for 15 minutes; 4°C) 
immediately, and the supernatant aliquoted into vials and stored frozen at -
20°c until assayed. 
Arterial blood samples were collected before, during CPB and for the first 
24- hours following CPB. Venous blood was collected after 24-hours following 
CPB due to removal of arterial lines. 
1. Parameters of sympatholysis 
a) Haemodynamic data: 
A full haemodynamic profile was obtained at the time points mentioned 
above. All pressure measurements (central venous pressure (CVP), pulmonary 
artery occlusion/ wedge pressure (PAOP), mean systemic arterial pressure 
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(MAP), mean pulmonary artery pressure (MPAP)) were made with reference 
to the midaxillary line. Cardiac output (CO) was measured in triplicate using 
the thermodilution technique (10-ml; 4 °C; 5 'Yo dextrose in water), and 
indexed to body mass (e.g. cardiac index (CI), L.min-1.m-2). Derived 
parameters (systemic vascular resistance index (SVRI), pulmonary vascular 
resistance index (PVRI) - dyne.sec.cm-5; left ventricular stroke work index 
(LVSWI) - g.g.m2) were calculated using standard formulae. 
b) Holter ECG analysis: 
Monitoring was commenced at the time-points described above. All patients 
were continuously monitored with a two-channel (CM5 & CM1), Holter ECG 
recorder (Tracker 2, Reynolds Medical, Hertford, UK) with the following 
characteristics; frequency response : 0.04Hz to 250 Hz -3dB and input 
sensitivity: 7 mV (pp), dynamic range. 
For general analysis, ECG recordings on Holter tapes were scanned visually 
using an ECG analysis system (series 1500; Marquette Electronics Ltd, 
Milwaukee, WI, USA). Continuous ST-segment trends and reports for 
arrhythmia counts were generated. For analysis of significant ST-segment 
changes, calibration with 2 Hz, 60 milliseconds pulses of 1 mV amplitude was 
done on all ECG channels. 
The incidence of myocardial ischaemia and the number of ischaemic episodes 
were determined after hard copy 12-lead ECG recordings were studied to 
exclude left bundle branch block or postoperative pericarditis. An ischaemic 
episode was defined as ST-segment shift from the baseline of ~0.1 mV 
depression at the J-point + 60 ms, or ~0.2 mV increase at the J-point, lasting 
for more than 60 seconds. The ST measurement point was not adjusted for 
heart rate. 
c) Myocardial infarction: 
• Creatine kinase & MB-isoenzyme measurement. 
Blood samples were collected in Lithium heparin tubes, stored at 4 °C and 
analysed within 24- hours by immunoinhibition and immunoprecipitation 
methods at 340 nm (KONE Diagnostics CK-NAC 981372 kit and KONE 
Optima analyser). The normal reference range in our institution is 24-195 
IU/L & 24-170 IU/L for males and females, respectively. CK-MB reference 
range is < 24 IU/L. 
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• Troponin-I measurement. 
Blood samples were collected in clotted tubes (no additive), centrifuged (3,500 
rpm for 15 minutes; 4°C) immediately, and the supernatant aliquoted into 
vials and stored at -20°C until assayed. Assay was done by a two site 
immunoassay using goat polyclonal antibodies to cardiac isoform of troponin I 
(Opus kit, Cat No. 703-050, and Opus Plus analyser, Behring Diagnostics UK 
Ltd). The normal reference range is < 0.05 µg/L for both adults and females. 
In this study the following criteria were used to define P-MI: 
• Q-wave P-MI: 
(i) CK-MB activity >50 IU/L occurring 21- h after CABG surgery [Farah et. 
al, 1984], or lasting more than 12 to 18- h [Delva et. al, 1978; Lee et. al, 
1986; Graeber et. al, 1986], or cTn-I levels >15 µg/L [Alyanakian et. al, 
1998]; and 
(ii) the appearance of new persistent Q-waves >0.04 s or equivalents (R-
wave increment leading to an R/5 ratio >1 in leads Vl and V2) in at least 2 
contiguous leads of the same vascular territory of the postoperative 
standard 12-lead ECG, using the Minnesota Code criteria [Blackburn et. 
al, 1960]. 
• Non-Q-wave P-MI: 
(i) CK-MB activity >50 IU/L occurring 21- h after CABG surgery [Farah et. 
al, 1984], or lasting more than 12 to 18- h [Delva et. al, 1978; Lee et. al, 
1986; Graeber et. al, 1986], or cTn-I levels >15 µg/L [Alyanakian et. al, 
1998]; and 
(ii) development of new persistent (> 24 hours) conduction abnormalities or 
ST-T alterations {ST segment depression or elevation >0.1 mV at 0.08s 
after the J point; T wave inversion) in at least 2 contiguous leads of the 
same vascular territory of the postoperative standard 12-lead ECG, using 
the Minnesota Code criteria [Blackburn et. al, 1960]. 
2. Parameters of stress response attenuation 
a) Plasma catecholamine (noradrenaline, adrenaline) measurements: 
Blood samples were collected in Lithium heparin tubes, centrifuged {3,500 rpm 
for 15 minutes; 4°C) immediately, and the supernatant aliquoted into vials 
containing reduced glutathione and EGTA and stored at -20°c until analysis 
by high-pressure liquid chromatography with electrochemical detection 
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[MacDonald et. al, 1985]. The reference range for noradrenaline and 
adrenaline is 0.5 - 3.5 nmol/L and 0.05 - 0.5 nmol/L, respectively. 
b) Serum cortisol measurement: 
Blood samples were collected in plain tubes, centrifuged (3,500 rpm for 15 
minutes; 4°C) immediately, and the supernatant aliquoted into vials and 
stored at -20°C until assayed. Serum concentrations were analysed in 
duplicate with commercially available enzyme linked immunoassay (ELISA) 
kits (Milenia Cortisol EIA, USA) [Seth et. al, 1988]. 
c) Plasma plasminogen activator inhibitor-1 measurement: 
Blood samples were collected in strong acidic citrate tubes (Biopool 
Stabilyte ™), centrifuged (3 500 rpm for 15 minutes; 4°C) immediately, and 
the supernatant aliquoted into vials and stored at -20°C until assayed. Serum 
concentrations were analysed in duplicate with commercially available enzyme 
linked immunoassay (ELISA) kits (TintElize®, Biopool International, USA). 
d) endothelin measurement: 
Blood samples were collected in EDT A-coated polystyrene tubes and 
centrifuged (3 500 rpm for 15 minutes; 4°C) immediately, and the 
supernatant aliquoted into vials and stored at -20°C until assayed. Endothelin 
was quantitatively determined using a Endothelin-1,2 (high sensitivity) [125I] 
assay system (Amersham International Ltd, United Kingdom). 
3. Parameters of analgesia and fast-tracking 
a) Visual analog pain score: 
Postoperative analgesia was scored by a Visual Analog Pain Score (VAS -
10cm scale) at the following time points; 1, 3, 6, 12, 18, 24, 48, 72-hours, day 
4 and day 5. 
b) Fast-track parameters: 
(i) A ventilation weaning score was used to assess the ability to wean the 
patient from ventilation in the intensive therapy unit. This was based on a 
scoring system where one point was given for each of 4 criteria, if they were 
met. The suitability to stop sedation and wean a patient from ventilation was 
done at 4- h following CPB. This did not preclude a patient from weaning and 
extubation prior to this if considered suitable by an independent ITU 
physician. Criteria used included the following parameters; 
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• haemodynamic stability - with minimal inotropic support, 
• warm peripheral temperature (axillary temperature> 35 °C), 
• minimal postoperative blood loss from the surgical site(< 100 ml.hr-1), 
• adequate gas exchange (Pa02/Fi02 > 25). 
(ii) A mini mental test consisting of 30 points was compiled to assess 
recovery of mental status following surgery, with different anaesthetic 
techniques. This was a test of short (object recollection) and long term 
(orientation in time, place and person) memory recall, the ability to perform 
simple mathematical mental tasks and simple hand-eye co-ordination tasks. 
The test was given to the patient preoperatively (evening prior to surgery) 
and repeated at 6- hours following CPB cessation. This postoperative score 
was compared to, and expressed as a percentage of the preoperative score. 
(iii) The timing of discharge from ITU and hospital was decided by an 
independent ITU physician, and by the postoperative surgical team, in 
conjunction with a physiotherapist, respectively. The decision to discharge 
from ITU were based on maintained or improved parameters of weaning, 
as discussed above. The decision to discharge from hospital was based on 
meeting the following criteria; haemodynamic stability, apyrexia, no other 
complications, and ability to mobilise adequately. 
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E. Data and Statistical Analyses: 
Data are expressed throughout as mean± standard error of the mean (sem) 
or median + range, where appropriate. 
For variables with multiple assessment times, area under curve (AUC) were 
calculated from the baseline measure using the trapezoid rule. For individual 
missing values in AUC measures, these values were interpolated if they were 
not consecutive (except for missing baseline values, where group means were 
used). This AUC analysis is sensitive to large, transient effects which may be 
masked by variability in individual t-tests at each time point. 
Statistical comparisons of continuous variables used parametric (two-tailed 
unpaired t-test for samples at a given time point between the two groups) or 
non-parametric repeated-measures analysis of variance (ANOVA) as 
appropriate, unless otherwise stated. 
Time to an event (e.g. time in ICU, time in hospital) and visual analog pain 
score was analysed with Wilcoxon tests. 
Two sided p-values are reported and statistical significance is defined as p < 
0.05. (UNISTAT®, Version 4 for windows, UNISTAT Ltd, London, UK). 
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IV.RESULTS 
A. Patient demographics 
Patients received an average of 2.4 and 2.8 grafts in the TEA and GA groups, 
respectively. Conduits included saphenous vein grafts in all patients, and an 
internal mammary artery graft to the left anterior descending (LAD) 
coronary artery in all except 2 patients (both were in the GA group). 
CPB duration ranged between 45 - 83 minutes (61.8 ± 4.3) in the TEA group. 
CPB duration was longer in the GA group, ranging from 51 - 125 minutes (84.7 
± 7.2). The longer CPB duration seen in the GA group, probably relates to the 
small number of patients studied in each group of this pilot study, and would 
probably even-out in a larger study. Of importance, however, is that the 
duration of aortic cross-clamp was similar between groups, ranging between 
19 - 57 minutes (36.8 ± 3.9 minutes) and 25 - 78 minutes (49.7 ± 6.2 minutes) 
in the TEA and GA groups, respectively. The aortic cross-clamp time is 
equivalent to the duration of the ischaemia and thus the period that dictates 
the severity of the myocardial ischaemia-reperfusion injury that occurs 
following CABG surgery. This similarity between cross clamp times of the 
two groups, therefore makes the groups comparable. With regards to other 
demographic indices (summarised in table 1.) the groups were comparable and 
all patients survived to hospital discharge. 
The age of the patients studied in the TEA and general anaesthetic groups 
ranged from 53 - 68 years (average 61.7 ± 1.9 years) and 46 - 75 years 
(average 60.6 ± 2.7 years), respectively. Of the twenty patients whose data 
are reported, two patients required re-operation for bleeding and one 
patient required prolonged mechanical ventilation for a confusional-state 
(post-pump delirium) following CPB (both patients were in the TEA group). 
Epidural catheters were left in situ for the planned 72-hours post-CPB in 7 
out of 10 patients, in the TEA group. Of the 3 patients whose epidural 
catheters did not remain in-situ for the full duration; 
• one was accidentally dislodged at 21- hours post-CPB 
• two were intentionally removed at 48-hours (one to allow commencement 
of warfarin therapy for a coronary artery endartrectomy done during 
surgery, and the other because the patient's epidural catheter had 
reached the allowed maximum in-situ stay of 5 days - due to surgery being 
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cancelled, due to the lack of an intensive care bed for postoperative 
recovery. 
There were no documented spinal haematomas causing neurological 
symptoms, no complaints of new severe radiating back pain or unexplained or 




Sex (male/female) 09 I 01. 09 I 01. 
Age, years (mean ± sem) 61.7 60.6 
(53 - 68) (46 - 75) 
Medical Treatment 
beta-blockers 6 9 
calcium antagonists 5 7 
ACE inhibitors 2 1 
nitrates 7 7 
aspirin 10 7 
NYHA functional class 
I-II/ III 7/3 10/0 
Previous medical history 
Diabetes Mellitus 3 3 
MI 5 7 
CABG 0 0 
PTCA 0 0 
LV ejection fraction >45'ro 10 10 
No. of obstructed vessels 
1 0 1 
2 3 4 
3 7 5 
left main stem 0 3 
No. of bypass grafts done 2.4 2.8 
Duration of aortic cross clamp 36.8 49.7 
Postoperative atrial fibrillation 2 3 
Table 1. Patient demographic data. 
Abbr.: ACE, angiotensin-converting enzyme; NYHA, New York Heart Association; MI, myocardial 
infarction; PTCA, percutaneous transluminal coronary angioplasty; L V, left ventricle. 
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B. Parameters of sympatholysis 
1. Haemodynamic parameters: 
There were no differences in heart rate, MAP, MPAP, filling pressures (CVP, 
PAOP), and derived indices (SVRI, PVRI, LVSWI) at the designated 
measuring times between the groups as a whole (table 2.). 
Baseline Pre-a>B 1 h. 3 h. 6 h. 12 h. 18 h. 
Heart rote (bpm) 170.6 ± 4.0 67.9 ± 3.6 71.2 ± 4.7 76.0 ± 2.0 79.4 ± 4.4 79.9 ± 2.8 77.5 ± 2.0 
164.0 ± 2.6 67.5 ± 4.0 77.8 ± 2.9 82.9 ± 3.4* 90.3 ± 4.5* 89.4 ± 4.5* 84.6 ± 5.8 
M»(mmHg) 81.4 ± 5.8 74.3 ± 3.7 77.8 ± 4.3 82.7 ± 2.9 80.0 ± 3.9 81.3 ± 2.8 83.0 ± 2.9 
74.2 ± 3.6 75.2 ± 2.2 79.7 ± 1.4 77.6 ± 2.4 78.5 ± 2.2 71.9 ± 1.5 79.1 ± 3.4 
PAOP(mmHg) 7.9 ± 0.8 7.9 ± 0.9 8.8 ± 0.8 8.2 ± 0.9 9.7 ± 1.2 9.3 ± 1.3 9.3 ± 1.2 
7.6 ± 1.0 6.8 ± 0.7 7.4 ± 0.6 7.3 ± 1.1 7.3 ± 0.6 8.5 ± 0.6 11.3 ± 1.3 
Cardiac index 2.9 ± 0.2 2.3 ±0.1 2.5 ± 0.1 2.4 ± 0.2 2.8 ± 0.3 2.8 ± 0.3 2.6±0.2 
(L.m1n·• .m~ 
2.0 ± 0.1 2.1 ± 0.2 2.4 ± 0.1 2.4 ± 0.3 2.8 ± 0.2 2.8 ± 0.2 2.4 ± 0.1 
SVRI 2837.7 2460.6 2291.2 2691.1 2186.4 2250.6 2443.3 
(dyne.scc.arf') + 226.7 + 205.7 ± 234.7 + 258.5 ± 184.9 + 219.7 ± 214.4 
2701.3 2879.8 2529.0 2545.5 2120.4 1900.7 2325.5 
± 114.3 ± 269.2 ± 161.5 ± 239.8 ± 126.8 ± 124.2 ± 153.0 
LVSWI (g.111.1112) 31.9 ± 4.3 31.5 ±3.3 31.1 ± 2.6 32.1 ± 3.1 33.8 ± 4.0 33.7 ± 3.3 33.4± 3.3 
29.0 ± 2.5 29.0 ± 2.8 29.7 ± 1.7 27.8 ± 3.1 30.3 ± 2.1 27.7 ± 2.0 26.6 ± 1.87 
Table 2. Haemodynamic parameters. Swan Ganz derived parameters, presented as mean± 
sem. TEA- and GA-group values are represented by the shaded and unshaded lines, 
respectively. No statistical significance was shown between groups, however, the GA group 
showed a significant (p< 0.05) increase in heart rate, when compared to baseline value at 3-
through to 12- hours following CPB. 
Abbr. : MAP, mean arterial pressure (systemic); PAOP, pulmonary artery occlusion (wedge) pressure; 
SVRI, systemic vascular resistance, indexed· L VSM, left ventricular stroke work, indexed· Pre-CPB, 
pre cardiopulmonary bypass; 1 h. - JBh, hours following cessation of CPB. 
The TEA group, however, showed consistently greater haemodynamic 
stability to perioperative stimuli, e.g. intubation, sternotomy, aortic 
cannulation, extubation (see figure 4, as an example). This is evidenced by a 
lesser change in heart rate when compared to baseline in the TEA group. In 
comparison, the GA group showed a statistically significant increase in heart 
rate when compared to baseline between 3-h and 12-h following the 
cessation of CPB. Furthermore, there was a clear trend towards requiring 
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less perioperative pharmacologic intervention; vasodilators (TEA vs. GA = 4 : 
10 patients) and inotropes (TEA vs. GA = 1 : 5 patients) in the TEA group. 
It is interesting to note that a similar number of patients required 
vasoconstriction with a-adrenergic agonists in both groups (TEA vs. GA = 6 : 
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Figure 4. Intra-operative trend of haemodynamics monitored in a patient during CABG 
surgery using the TEA technique. This figure is only used as a representative example to 
illustrate the haemodynamic stability obtained with the TEA technique. 
Abbr.: HR= heart rate, APS, APM, APD = systolic, mean, diastolic arterial pressure, respectively. 
Previous studies [Krukenkamp et. al, 1987] suggest that the relationship 
between end-diastolic volume and stroke work (calculated as the area of the 
pressure-volume loop) is linear, afterload independent, and sensitive to the 
inotropic state. 
For the want of a better method of assessing ventricular function in the 
clinical setting, we constructed a left ventricular function curve (figure 6.), 
using LV-stroke work [y-axis] plotted against preload (using PAOP as a 
substitute for end-diastolic volume) on the x-axis. Mean haemodynamic 
values were used for each group. 
Movement along the same plot of the left ventricular function curve (see 
figure 5; line A-B) reflects preservation of the inotropic state [Frank-
Starling mechanism], as opposed to a downward movement (see figure 5; line 
B-C) to another ventricular function plot, which would represent a 
deterioration in the state of inotropy [Suga et. al, 1991]. 
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,( -IT = ::s::rm~ r.nrrf:r::rd:ffffy 
A-C =~ contractility 
Figure 5 . Left ventricular function curve. Movement along the line from point A to B 
reflects preservation of the inotropic state [Frank-Starling mechanism]. Downward movement 
from point B to C represents a deterioration in the state of inotropy. 
Abbr.: l V = left ventricle. 
By constructing ventricular function curves, our data suggests that the 
inotropic state is maintained at baseline level in the early postoperative 
period in the TEA group. Thus suggesting early postoperative recovery or 
maintained LV function in this group. This is in contrast to a persistent state 
of lower inotropy, suggestive of myocardial stunning in the GA group. 
Using a similar method, Mangano et. al, [1985] reported that transient RV 
function depression occurs in the immediate post-CPB period as evidenced by 
a deterioration in RV stroke work index / CVP relationships, with 
normalisation or gradual recovery of function over the succeeding 24 hours. 
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Figure 6. Left ventricular function curve. 
When compared to the pre-operative position on the Frank-Starling curve (broken line), we 
see that early postoperative ventricular function is preserved in the TEA group(= D). The GA 
group (= 0 ), however, moves downward from this Frank-Starling curve, suggesting 
deterioration in the state of inotropy. 
2. Holter ECG analysis: 
No differences were observed between TEA and GA groups with regards 
to pre-operative ST-segment changes (elevation and depression) and 
postoperative ST-segment depression. 
Postoperatively, however, there were significantly more ST-segment 
elevations in the GA group. The maximum ST-segment elevation (mm; p<0.05) 
and duration of ST-segment elevation greater than 2 mm (hours; p <0.005, 
Mann-Whitney-U test; see figure 7.) were significantly elevated in the GA 
group, within the first 24- h following CPB. Significantly more patients in the 
GA group than in the TEA group (6/9 vs. 1/9 patients, respectively; p = 
0.025, Fisher's Exact test) presented with episodes of ST-segment elevation 
>2 mm within the first 24- hours following CPB. 
The duration of, and number of patients with ST-segment elevation showed a 
reduction at 48- hours (3/9 vs. 2/9 patients) and 72- hours (2/6 vs. 0/5 
patients) following CPB in the GA and TEA groups, respectively. No 
statistical significant difference was observed between groups at 48- hours 
and 72- hours. These data, are suggestive of coronary artery 
vasoconstriction occurring in the early postoperative period following CPB in 
the GA group, and this is despite the use of intravenous glyceryl-trinitrate 
infusions for 24 - 48 hours postoperatively, in all patients within the GA 
group (GA vs. TEA; 10/4 patients, respectively). 







T -0.0 I I 
Pre CPB 24 h 48 h 72 h 
Figure 7 . Holter monitoring. 
Duration (hours; mean iJ sem) of ST-segment elevation >2 mm during 72- h of postoperative 
Holter monitoring. 
Abbr. 24- h, 48- h, 72- h, hours following cessation of cardiopulmonary bypass. * * = p < 0.005; Mann-
Whitney-U test. 
3. Perioperative myocardial infarction: 
• CK-MB isoenzyme and cTn-I levels (figure 8.) were similar between TEA 
and GA-groups preoperatively. 
Postoperatively, CK-MB levels trended towards lower values in the TEA 
group, however these did not reach statistical significance. 
cTn-I levels were significantly lower at 6- h post-CPB (3.5 ± 0.6 vs. 12.4 ± 4.2 
µg/L; p = 0.05) and for AUC0_6h (18.1 ± 2.8 vs. 58.1 ± 19.1; p < 0.05) in the TEA 
group when compared to the GA group, respectively. 







base 3 h 6 h 12 h 24 h 72 h Day 5 
Figure 8. Cardiac Troponin-I. Significantly lower cTn-I levels were seen in the TEA 
group at 6- hours following CPB, and for the area under curve (AUC 0-6 hours). 
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• Total CK levels 
Total CK values (figure 9.) were significantly lower in the TEA group at 1- h 
(300.0 ± 32.5 vs. 486.3 ± 50.5 IU/L; p < 0.01), 3- h ( 405.0 ± 41.5 vs. 624.1 ± 
62.6 IU/L; p < 0.01), 6- h (460.8 ± 37.9 vs. 758.8 ± 126.2 IU/L; p < 0.05) and 
72- h (352.0 ± 54.2 vs. 985.3 ± 321.4 IU/L; p < 0.05). 
Furthermore, a significant reduction was seen for AUC0-12h in the TEA group 
(5773.0 ± 443.3 vs. 8539.1 ± 1119.1 IU/L; p < 0.05), with a similar trend in 
AUCo-nh and AUCo-Day 5 . 
Total CK values peaked earlier in the TEA group at 24- h post CPB, in 









base 1 h 3 h 6 h 12 h 24 h 72 h D 5 
Figure 9. Total creatine kinase plasma levels. 
Abbr. Base, pre-cardiopulmonary bypass; h, hours & D, day following cessation of cardiopulmonary 
bypass. * * = p < 0.01; * = p < 0.05. 
• P-MI 
Using the predefined criteria to diagnose non-Q and Q-wave myocardial 
infarctions; 
* 3 patients in the GA group suffered non-Q wave myocardial infarctions as 
opposed to 1 patient in the TEA group. 
* Neither group suffered any new Q-wave myocardial infarction. 
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C. Parameters of stress response attenuation 
1. Plasma catecholamine (noradrenaline, adrenaline) measurements: 
Throughout the perioperative period the catecholamine levels were 
consistently lower in the TEA group than in the GA group. 
• Noradrenaline levels (figure 10.) were significantly lower during CPB 
(1.10 ± 0.32 vs. 2.57 ± 0.39 nmol/L; p < 0.01), at 1- h (1.07 ± 0.25 vs. 1.93 ± 
0.24 nmol/L; p < 0.05), 12- h (3.25 ± 0.56 vs. 4.81 ± 0.37 nmol/L; p < 0.05), 
and 24- h (3.61 ± 0.69 vs. 6.11 ± 0.81 nmol/L; p < 0.05) following CPB in the 
TEA group when compared to the GA group. 
Statistical significant reductions for AUCo-6, 0-12. o-24, o-72 hours (0-72-h; 250.8 






base CPB AXC 1 h 3 h 6 h 12 h 24 h 72 h 
Figure 10. Noradrenaline plasma levels. 
The broken line represents the upper range of physiologic levels of serum noradrenaline (3.5 
nmol/L). 
Abbr. Base, pre-cardiopulmonary bypass; AXC, aortic cross clamp release; h, hours following cessation of 
cardiopulmonary bypass. 
* * = p < 0.01; * = p < 0.05. 
It is of interest to note that noradrenaline levels were maintained below 
the upper reference range intraoperatively by both anaesthetic 
techniques. However, when compared to the TEA group, the GA group 
showed earlier elevation of levels above the reference range in the post 
operative period (3- h vs. 24- h post CPB, respectively). 
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• Adrenaline levels (figure 11.) remained unchanged in the perioperative 
period in the TEA group and were, similarly, significantly lower when 
compared to the GA group during CPB (0.49 ± 0.11 vs. 1.36 ± 0.21 nmol/L; 
p < 0.01). Statistical significant differences were shown between the 












base CPB AXC 1 h 3 h 6 h 12 h 24 h 72 h 
Figure 11 . Adrenaline plasma levels. 
The broken line represents the upper range of physiologic levels of serum adrenaline (0.5 
nmol/L). * * = p < 0.Ql; o = p < 0.05 for AUCo-6, 0-12, 0-24 hours. 
Abbr. Base, pre-cardiopulmonary bypass; AXC, aortic cross clamp release; h, hours following cessation of 
cardiopulmonary bypass. 
2. Serum cortisol measurement: 
Cortisol levels (figure 12.) peaked at 6- hours following cessation of CPB, 










base 1 h 3 h 6 h 12 h 24 h 72 h Day 5 
Figure 12. Cortisol serum levels . 
Abbr. Base, pre-cardiopulmonary bypass; h, hours following cessation of cardiopulmonary bypass. 
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3. Plasma plasminogen activator inhibitor-1 (PAI-1) measurement: 
Plasminogen activator inhibitor-1 levels (figure 13.) were significantly lower 
in the TEA group at 72- hours (24.3 ± 2.9 vs. 34.1 ± 3.5 µg/L, p < 0.05) 
following the cessation of CPB, with a trend (p = 0.06) to reduction in AUC 
0-5 postoperative days in the TEA group . 
On termination of the epidural infusion, PAI-1 levels return to correspond 









base 12 h 24 h 72 h Day 5 
Figure 13. Plasminogen activator inhibitor-1 levels. 
Abbr. Base, pre-cardiopulmonary bypass; h, hours following cessation of cardiopulmonary bypass. 
*= p < 0.05. 
4. endothelin measurement: 
Endothelin-1,2 levels were significantly lower in the TEA group during CPB 
(23.4 ± 2.5 vs. 40.3 ± 7.4 ng/L, p < 0.05). No differences, however, were 
observed between groups in the early postoperative period. 
RIEDEL B.J.C.J . 50 
D. Parameters of analgesia and fast-tracking 
1. Visual analog pain score: 
Visual analog pain scoring (figure 14.) showed significant reductions at all 
postoperative time points (p < 0.01 at 24- hours, p < 0.02 at 6-, 12-, day 2, 
day 3 and day 4 and p < 0.05 at 18- hours and day 5 following CPB). A 
marked leftward shift was seen in the TEA group, which correlates with 
earlier awakening and extubation of patients in this group. 
VAS 
*** OGA 10 
** ITEA 
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Figure 14. Visual analog pain score. 
No error bar is seen at 3- h post cardiopulmonary bypass in the GA group - this is because 
only one patient was extubated in this group, at this time point. Data is presented as median+ 
upper range. * = p< 0.05; ** = p< 0.02; *** = p< 0.01; Wilcoxon two sample test. 
Abbr. Base, pre-cardiopulmonary bypass; h, hours following cessation of cardiopulmonary bypass. 
2. Fast-track parameters: 
Ability to wean the patient from ventilation in the intensive care, as 
assessed by a scoring system at 4- h following CPB, did not differ between 
the TEA and GA groups. 
Despite similar weaning assessment scores (3.8 ± 1.3 vs. 3.5 ± 0.3) and 
similar gas exchange (Pa02/Fi02 : 48.3 ± 5.7 vs. 56.4 ± 10.6) in the TEA 
and GA groups, respectively the TEA group showed significantly improved 
time to extubation (3.7 ± 0.6 h vs. 6.9 ± 1.2 h; p < 0.05). 
This improved time to extubation may be attributed to; 
• the opioid free anaesthetic technique, 
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• significantly improved analgesia, 
• and a trend towards improved alertness in the TEA group, as assessed 
by a mini-mental test conducted at 6- h following CPB (87.8 ± 10.7 io vs. 
61.4 ± 13.7 'Yo). 
No difference was shown between groups with respect to time to 
discharge from ITU and time to discharge from hospital. 
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V. DISCUSSION 
In this pilot study, both the TEA and GA groups were well matched for 
demographic data, surgical intervention and for the duration of ischaemia 
(aortic cross-clamp time) and therefore groups can be regarded as being 
comparable. The differences in the demographic data were balanced out by 
other factors in each group, e .g. 3 vs. 0 patients were in a NYHA functional 
class III status; 6 vs. 9 patients were on beta-blockers; 2 vs. 1 were on ACE-
inhibitors; 5 vs. 7 had previous MI's; 7 vs. 5 had triple vessel disease, in the 
TEA and GA groups, respectively. 
Ischaemia-reperfusion injury is the single most important factor that can 
detrimentally influence outcome of myocardial function following cardiac 
surgery and this correlates closely with aortic cross clamp duration. 
Importantly, the duration of aortic cross clamp was similar between the TEA 
and GA groups. A difference was observed in the duration of CPB, however, 
no factor was identified that could have contributed to this, for example 
more difficult vessels. This observed difference in cardiopulmonary bypass 
duration between the groups may relate to the relatively small size (n = 10) 
of both groups, and it would be expected to become insignificant in a follow-
up study with a larger population. 
We as anaesthesiologists aim to induce sympatholysis, suppress the stress 
response and provide superlative analgesia in an attempt to prevent 
perioperative complications e.g. myocardial infarction. 
This trial was designed as a pilot study to investigate the following 
hypothesis: that TEA provides a more favourable perioperative 
physiological milieu in the setting of cardiac surgery. 
In an attempt to prove or disprove this hypothesis we investigated the 
impact that TEA may have on sympatholysis, stress response attenuation 
and perioperative analgesia, specifically in the setting of patients undergoing 
cardiac surgery for coronary artery disease. 
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Does TEA induce sympatholysis, suppress the stress response and 
improve analgesia in the cardiac patient ? . 
Based on the fact that myocardial ischaemia is the single most important, 
potentially reversible risk factor for cardiovascular complications, we use 
surrogate markers of ischaemic injury e.g. ST-segment changes and 
echocardiography, for the detection of regional wall motion abnormalities. 
These surrogate markers are used in an attempt to allow early detection of 
metabolic derangement, and thereby facilitate reversal of the process 
through timely therapeutic interventions. 
Myocardial ischaemia is a state of coronary supply/demand imbalance and 
two principle factors have been identified that contribute to the majority of 
postoperative ischaemic events, these include; 
• an exaggerated sympathetic response and, 
• endothelial dysfunction. 
The impact of TEA on sympatholysis and stress response was explored in 
this trial, however we did not explore the impact of TEA on endothelial 
dysfunction (associated with atherosclerosis and ischemia-reperfusion 
injury). 
Haemodynamic instability (tachycardia, hypertension) can result in increased 
myocardial oxygen demand, which especially in the presence of restricted 
supply (coronary artery atherosclerosis) may promote myocardial ischaemia. 
Most experimental and clinical [Blomberg et. al, 1989; Liem et. al, 1989; 
Stenseth et. al, 1994] studies agree that TEA provides greater 
haemodynamic stability and in particular, results in a reduction in the 
incidence of hypertension during CPB and in the early postoperative period, 
with fewer pharmacological interventions being required. 
Our data confirmed these findings to a certain degree, as was evidenced by 
lack of a significant increase in heart rate, when compared to baseline values 
in the TEA group. The GA group showed a significant increase in heart rate 
in the early postoperative period, when compared to baseline. In keeping with 
these previous studies, the greater haemodynamic stability by TEA is 
further suggested by the requirement for less perioperative pharmacologic 
intervention in this group; e.g. vasodilators (TEA vs. GA = 4 : 10 patients), and 
inotropes (TEA vs. GA = 1 : 5 patients). These pharmacological therapies 
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were used in order to maintain acceptable perioperative systemic perfusion 
pressures. 
Our data, however, showed no differences, at the designated measuring time 
points, between the groups as a whole, with regards to other haemodynamic 
variables e.g. mean arterial blood pressure, and thermodilution-derived 
indices e.g. cardiac index, LVSWI, SVRI (table 2.). This may be due to; 
• the unrestricted use of anaesthetic, vasodilator and inotropic agents in 
order to maintain haemodynamic stability in both groups 
• the fact that haemodynamic measurements were not made at the time 
points known to be stimulating, that is, at intubation, surgical incision, 
sternotomy, aortic cannulation, and extubation. 
Previous fears have been expressed that epidural analgesia and other 
neuraxial techniques may reduce coronary perfusion pressure, thereby 
predisposing to myocardial ischaemia. It is important to note that our 
technique, of providing a selective (Tl-4) epidural blockade, maintained 
cardiac output and systemic vascular resistance, when compared to the GA 
group. This suggests that our TEA technique maintained coronary perfusion 
pressure and emphasises the importance of a high TEA approach, thereby 
avoiding vasodilation of the splanchnic bed. 
This preservation of coronary perfusion pressure is also subsequently 
reflected by the absence of ST-segment changes on perioperative Holter 
ECG monitoring (figure 7.) in the TEA group. The ST-segment changes 
observed in the GA group were suggestive of postoperative coronary artery 
vasoconstriction occurring in the early postoperative period. These ST-
segment changes occurred despite all GA patients (vs. only 4 patients in the 
TEA group) receiving prophylactic nitroglycerine infusions. These infusions 
were maintained throughout the perioperative period and maintained for 24-
to 48- hours into the postoperative period. The nitroglycerine was 
administered in the GA group as part of our standardised intra- and post-
operative care protocols used in out institution. The TEA group was in fact 
biased against because nitroglycerine infusions were only used in the 4 TEA 
patients for blood pressure control in the postoperative period. It was noted 
that patients with epidurals tended to reset their postoperative blood 
pressures towards their pre-operative values. 
If we remember that epicardial coronary arteries are predominantly 
innervated by a-receptors and sympathetic stimulation of these receptors 
reduces myocardial oxygen delivery through arterial vasoconstriction and 
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redistribution of blood flow away from the subendocardium. It is therefore 
not surprising that coronary vasoconstriction is abundant in the early 
postoperative period of the GA group. This sympathetic response can be 
overridden by metabolic autoregulation in patients with a normal intact 
endothelium, resulting in regional vasodilation. However, as shown by Nobel 
et. al [1990], this post-stenotic vasodilator reserve is lost in patients with 
endothelial dysfunction e.g. atherosclerosis, hypercholesterolaemia, 
hypertension and diabetes mellitus. This was confirmed by Johannsen et al. 
(1982] who showed that despite infusing adenosine into atherosclerotic 
vessels they were unable to overcome sympathetic-induced vasoconstriction. 
It is suggested that endothelial dysfunction proceeds the development of 
macroscopic atherosclerotic lesions [Ross, 1993]. This is characteristic of 
unstable atherosclerotic lesions, which tend to have non-critical stenoses -
with impaired vasodilation and an exaggerated response to sympathetic 
stimulation, and unstable lipid bullae below the plaque surface. 
The presence of sympathetic activation, coronary vasoconstriction and 
increased shear stress may predispose to plaque fissuring, thereby exposing 
the subendothelial collagen and lipids (known strong activators of the 
coagulation cascade). This leads to thrombus formation and subsequent 
reduction in myocardial metabolic supply. During CABG surgery these 
unstable lesions may be bypassed, but this does not prevent this dynamic 
pathological process from being triggered by the sympathetic activation and 
increased shear stress that occurs during the perioperative period and thus 
an evolving plaque and / or thrombus may embolise, resulting in perioperative 
morbidity and mortality. Clearly, this is a process that could benefit from 
the sympatholysis. 
Endothelial dysfunction is characteristic of the group of patients we studied, 
and this dysfunction presents with an imbalance in the endothelial regulated 
vasodilator/constrictor and pro/anticoagulant equilibrium. Characteristically 
there is a decreased response to vasodilatory mediators e.g. serotonin, 
bradykinin and shear stress, as well as an exhibition of an exaggerated 
response to a-agonists, and an attenuated response to p-agonists. 
Apart from the disease process, other perioperative factors are known to 
promote and exaggerate this endothelial dysequilibrium. These include; 
• surgical trauma with intimal injury and endothelial denudation at the site 
of the vascular anastomosis - with a resultant focal loss of endothelial-
dependent endogenous vasodilators, e.g. nitric oxide (EDRF) and 
prostacyclin (PGI2). 
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• an increase in sympathetic neural outflow and increased systemic stress 
response mediated by CPB and postoperative pain. 
In addition to the exaggerated sympathetic response and endothelial 
dysfunction witnessed in the perioperative period of patients undergoing 
CABG surgery, any one and more commonly a combination of various 
postoperative factors could contribute to myocardial ischaemia. An example 
may be poor postoperative analgesia resulting in intermittent episodes of 
tachycardia, thereby increasing myocardial oxygen consumption. This poor 
postoperative analgesia may further result in a reluctance to inspire 
adequately, promoting the development of postoperative atelectasis, VIQ 
mismatching and impaired oxygenation. This impaired oxygenation and the 
reduction in diastolic filling time by tachycardia, combined with possible 
postoperative anaemia and stress-response induced hypercoagulability may 
all contribute to a reduction in myocardial oxygen delivery. These factors 
may therefore result in subsequent ischaemia. 
Our data, suggests that TEA promotes sympatholysis, stress response 
attenuation and improved analgesia and thereby facilitates an improved 
intra- and postoperative physiological milieu. This is supported by the 
following results obtained in our pilot study; 
• improved haemodynamic stability 
• direct selective coronary artery vasodilation (figure 7.), 
• reduced systemic circulating catecholamines (figure 10, 11.) 
• reduced inhibition of fibrinolysis by plasminogen activator (figure 13.) 
• reduced postoperative tachycardia, V IQ mismatch and impaired 
oxygenation through improved analgesia (table 2, figure 14.). 
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Will the more favourable perioperative physiological milieu provided by 
TEA translate into improved patient outcome ? . 
It is our goal as anaesthetists to prevent poor perioperative cardiac outcome 
(e.g. P-MI) in patients undergoing cardiac surgery, as well those at increased 
risk of CAD undergoing non-cardiac surgery. Poor perioperative cardiac 
outcome can potentially compromise the patient's life or quality of life after 
surgery, as well result in an increase in the cost of patient care. 
Whether TEA may potentially confer a better postoperative cardiac 
outcome following CABG surgery requires further study in a larger 
population of patients. However, this pilot study suggests that TEA may have 
a role in attenuating the vasodilator/constrictor, pro/anticoagulant imbalance 
that occurs in the perioperative period (as discussed above) and therefore 
may potentially impact, 
• the incidence of P-MI 
• the incidence of early graft occlusion. 
• Perioperative myocardial infarction. 
The importance of preventing ischaemic injury was highlighted by Guiteras 
Val et. al [1983]. They reported that 49 i'o of patients who suffered a P-MI 
following CABG surgery had either re-infarcted or died at the time of their 
2- year follow up, as opposed to 4 i'o in patients in those who did not develop 
a new P-MI. Furthermore, it has been shown that survivors of complications 
following cardiac surgery result in annual additional costs estimated at 
US$750 million for in-hospital treatment and US$500 million for follow-up 
care [Harrison, 1985]. 
This data is supported by Slogoff et. al, [1985], who showed a 3-fold 
increase of P-MI in patients who developed perioperative ischaemia in 
patients undergoing CABG surgery. Hence, the increase in P-MI in our GA 
group correlates with the increased ST-segment changes in this group. 
The incidence of P-MI in CABG surgery varies according to the diagnostic 
methods and criteria used. Slogoff et. al [1985] using ECG and enzymatic 
criteria estimated the incidence of P-MI at 4.lio, compared to Cheng et. al 
[1978], who with the addition of technetium-pyrophosphate scanning 
(SPECT) showed a 25i'o incidence of P-MI, of which 2.8io were Q-wave 
infarctions. 
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Using more sensitive enzyme studies (cardiac isoform of troponin-I -
discussed below), we showed a similar incidence of P-MI in our GA group, 
compared to that seen by Cheng et. al. Using the predefined criteria (see 
discussion below) to diagnose non-Q and Q-wave myocardial infarctions we 
showed that 3 patients (30 %) in the GA group suffered non-Q wave 
myocardial infarctions as opposed to 1 patient in the TEA group. Neither 
group suffered any new Q-wave myocardial infarction. Arguably, no 
statistical difference is shown between the GA and TEA groups in this small 
study and it will need to be repeated in a larger group of patients. The 
reduction in the incidence of P-MI in the TEA group, however, holds promise 
and suggests that a more favourable perioperative physiological milieu is 
conducive to an improved/ preserved outcome of myocardial function. 
No clear consensus exists regarding the criteria that should be applied to 
creatine kinase-MB isoenzyme (CK-MB) or the cardiac isoform of troponin-I 
(cTn-I) with regards to the diagnosis of Q- and non-Q wave P-MI following 
CABG surgery. 
The numerous factors that make the choice of threshold for P-MI difficult 
include; 
• lack of cardiospecificity - despite higher sensitivity and specificity CK-MB 
and Troponin-T are still not 100 'Yo cardiospecific. It is suggested that 
Troponin I has the most cardio-specificity. 
• a peak is evidenced in both CK-MB activity (between 4- to 8-h after CABG 
surgery) [Olthof et. al, 1983] and in cTn-I (between 6 to 12-h after CABG 
surgery) due to surgical trauma and postbypass washout. These factors 
produce a short-term liberation of enzymes into the circulation in all 
patients, including those without P-MI. 
• the lack of standardisation of the assays currently available. This yields 
different reference ranges, hence, making the comparison among 
different studies difficult. This is true for both CK-MB and cTn-I. 
(The reference ranges for CK-MB (using an immunoinhibition technique 
[Merck, Darmstadt, Germany]) are as follows : <10.0 IU/L at 25 °C, <14.4 
IU/L at 30 °C, and <24.0 IU/L at 37 °C. The latter value is the upper limit 
of the normal reference range in our laboratories, where CK-MB activity 
is measured with a similar immunoinhibition technique at 37 °C rather than 
at 25 or 30 °C.) 
It is suggested that using CK-MB activity levels (immunoinhibition technique) 
>50 IU/L (twice the upper reference range), occurring 21- h after CABG 
surgery [Farah et. al, 1984], and lasting more than 12 to 18- hare diagnostic 
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of P-MI [Lee et. al, 1986], and that cTn-I levels (immunoassay technique) >15 
µg/L occurring within 24 to 48- h after CABG surgery are diagnostic of P-
MI [Alyanakian et. al, 1998]. 
With the addition of the more sensitive and specific cardiac isoform of 
troponin-I to our diagnostic armamentarium we may now be able to monitor 
the incidence of P-MI following CABG more accurately, without the need for 
more advanced and less accessible technologies like SPECT as used by Cheng 
et. al [1978]. Troponins are a complex of regulatory proteins that regulate 
the calcium-mediated interaction of actin and myosin and are uniquely 
present in striated muscle. Unlike Troponin-T, cTn-I is highly specific for 
myocardial injury (Opus 2 site cTn-I immunoassay vs. Opus CK-MB sensitivity 
is 93.9% and 95.9io, respectively and specificity is 97.4% and 85.3io, 
respectively) and furthermore, unlike other cardiac markers (CK-MB) cTn-I 
levels may remain elevated in serum for several days before returning to 
normal. Perioperative necrosis results in a more prolonged and slower release 
of enzyme, with a delayed (10 to 16- h) peak in postoperative CK-MB activity 
and cTn-I levels, aiding the ability to distinguish P-MI from enzymatic rise 
associated with brief ischaemia-reperfusion injury and surgical trauma 
associated with cardiac surgery. 
Gao et. al [1997] identified cTn-I proteolysis as the cause of the reversible 
cardiac dysfunction in myocardial stunning, with a subsequent report by 
McDonough et. al [1999] suggesting that severe ischaemia/reperfusion injury 
is associated with proteolysis on N-terminal amino acids of cTn-I. What is 
intriguing is that proteolysis of cTn-I may be an initial or triggering insult in 
engaging the hypertrophic process through unknown transcriptional and 
translational mechanisms. This is supported by extensive evidence that 
mutations in sarcomeric proteins are genetically linked to familial 
hypertrophic cardiomyopathy [Kimura et. al, 1997]. To what degree this is 
true for cTn-I release following cardiac surgery is not known, however, it 
seems prudent that all attempts to reduce an ischaemia-reperfusion injury 
and subsequent cTn-I release are warranted. 
• Coronary artery graft occlusion 
Current experience in peripheral vascular surgery suggests that patients 
requiring re-operation for graft thrombosis have higher circulating 
concentrations of noradrenaline [Parker et. al, 1993] and plasminogen 
activator inhibitor-! (with impaired fibrinolytic activity) in the perioperative 
period. Circulating levels of both these substances [Rosenfeld et. al, 1993] 
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and the incidence of peripheral vascular graft occlusion [Rosenfeld et. al, 
1993; Tuman et. al, 1991] have been shown to be reduced by epidural 
anesthesia. Whether this demonstrates a cause and effect relationship is 
debatable. Furthermore and in contrast, other groups [Cook et. al, 1986; 
Pierce et. al, 1997] have failed to show any benefit of regional anaesthesia in 
reducing the incidence of graft thrombosis after peripheral vascular 
surgery. This point was debated in an earlier section of this text. 
In our experience, post-operative catecholamine concentrations (especially 
noradrenaline - figure 10.) are elevated up to 72 hours following CABG 
surgery. Postoperative catecholamine levels values exceed those values 
obtained under controlled intraoperative conditions, suggesting that 
postoperative analgesia is sub-optimal and that it may well be the most 
important factor influencing the frequency of thrombotic complications and 
early postoperative graft occlusion. 
Our data suggests that TEA significantly attenuates the increase in 
intraoperative noradrenaline levels, and maintains this effect up to 24- hours 
(vs. 3 hours in the GA group - figure 10.) following CPB. Although greater 
significance would possibly become evident in a larger study population, TEA 
also attenuates the increase in plasminogen-activator-1 levels (figure 13.). 
The beneficial effect of TEA on PAI-1 levels warrants further investigation 
into the impact of TEA on the dynamic effect of thrombus formation, as 
measured by thromboelastography (see section titled ... future). 
TEA may impact the incidence of early phase graft occlusion. This 
postulation is based on the knowledge that a combination of factors exist in 
the immediate peri-operative period that promote early graft occlusion. 
These include; surgical technique that exposes the sub-endothelium and thus 
promote thrombus formation, the promotion of a stress response induced by 
surgery - resulting in postoperative hypercoagulability, and high levels of 
catecholamines that may promote vasoconstriction with resultant poor run-
off from distal coronary vessels. 
The use of the internal mammary artery to the left anterior descending 
coronary artery is associated with patency rates of greater than 90'Yo. 
Whether other arterial conduits will yield a similar patency rate is still not 
known, however, the use of multiple arterial grafts may be associated with 
an increase in perioperative morbidity related to increased reactivity of 
these arterial conduits to circulating catecholamines, with the development 
of spasm and ischaemia. 
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These and other data suggest that TEA may have a role in prevention of 
early graft occlusion through the reduction in circulating catecholamines and 
preventing the postoperative hypercoagulability. The possibility that TEA 
may reduce the incidence of early graft occlusion, especially in patients 
undergoing multiple arterial grafts and those with poor distal vessels, 
thereby reducing the need for re-operation coronary surgery, still needs to 
be explored and may warrant angiographic studies in the postoperative 
period to confirm this. 
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Does TEA facilitate fast tracking ? . 
Both financial and clinical considerations have prompted many anaesthetists 
to advocate early extubation after uncomplicated revascularisation instead 
of traditional prolonged respiratory support. 
The studies by Joachimsson et al. [1989] and Liem et al. [1992], comparing 
the influence of a general anaesthetic technique using intravenous opioids 
with a combined regional and general anaesthetic technique showed that TEA 
provides superlative analgesia, thereby; obviating the need for opioids, 
reducing the duration of mechanical ventilation, facilitating improved 
respiratory function with early extubation and enhanced control of blood 
pressure in the postoperative period. 
Our data suggests that - through the facilitation of earlier extubation, 
improved respiratory function, improved alertness (as assessed by a mini-
mental test) and improved analgesia (figure 14.) in the TEA group, that TEA 
is suited as an anaesthetic technique for 'fast-tracking' suitable CABG 
patients. These data support the findings of Joachimsson et. al [1989] and 
Liem et. al [1992]. 
The newer ultra-short acting opioids e.g. remifentanil, through superlative 
stress response attenuation and allowing almost immediate awakening and 
extubation, are also ideally suited to facilitate 'fast-tracking' of suitable 
CABG patients. However, these opioids lack postoperative analgesic 
properties, and therefore it may be advisable to explore the combination of 
TEA with these newer opioids, as a potential mechanism to overcome their 
limitation. 
It is important that our anaesthetic techniques also attempt to prevent 
injury to the skeletal muscle and other end-organs, so that the strive to 
early mobilisation and discharge from hospital is facilitated. The non-
pulsatile flow of CPB and increase in circulating stress hormones during and 
after CPB may result in an ischaemia-reperfusion injury to the skeletal 
muscle bed. This is evidenced as an elevation in total creatine kinase (figure 
9.), peaking at 72- hours following CABG surgery. The use of TEA was 
associated with significant reductions in the total creatine kinase levels, 
together with an earlier peak at 24- hours following CPB. This may be 
suggestive of improved perfusion of the skeletal muscle bed that is probably 
facilitated by reduced levels of circulating catecholamines (especially 
noradrenaline) in the TEA group, and this supports the feasibility of earlier 
mobilisation and fast tracking by TEA. 
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The role of TEA in minimally invasive coronary artery bypass graft 
(MIDCAB) surgery ? . 
The increasing interest in the use of minimally invasive coronary artery 
bypass graft (MIDCAB) surgery is driven by two motives. Firstly, improved 
patient care - attempting to reduce CPB-related morbidity e.g. inflammatory 
response and secondly, pressures to reduce medical resource consumption -
attempting to expedite postoperative recovery and reduce the duration of 
hospital stay [Hensley. 
MIDCAB surgery is done on a beating heart. This maintenance of myocardial 
contraction facilitates lymphatic removal of interstitial fluid, thereby 
avoiding post-arrest ventricular dysfunction due to edema. During MIDCAB 
surgery, however, regional ischaemia (15 - 20 minutes) is still induced in 
order to facilitate anastomosis of the distal end of the internal mammary 
artery to the LAD on the beating heart. This inevitably predisposes to 
myocardial ischaemia and a ischaemia-reperfusion injury may occur e.g. 
postischemic myocardial dysfunction (stunning). This myocardial dysfunction 
may be counter productive to the original objective of this surgical 
procedure, namely rapid convalescence and home-discharge. 
The inability to use conventional myocardial protective strategies that are 
used during CPB (cardioplegia-induced electromechanical arrest) in MIDCAB 
surgery necessitates we search for other methods of myocardial protection. 
Three possible techniques used in conventional CABG surgery may prove 
useful in MIDCAB surgery. These include; ischaemic preconditioning 
[Jacobsohn et. al, 1997], pre-treatment with intravenous substrate (s) and 
thoracic epidural anaesthetic techniques. 
Experimental data showing improved recovery of systolic thickening following 
ischaemia (reduced stunning) [Rolf et. al, 1996] and a reduction in myocardial 
infarct size [Klassen et. al, 1980; Davis et. al, 1986] support the myocardial 
protective properties of TEA and suggest that TEA is ideal as a method of 
myocardial protection during MIDCAB surgery, where conventional 
protection by electromechanical arrest cannot be used. This is further 
supported by our data, showing a preserved state of inotropy in the TEA 
group, when compared to the GA group - see left ventricular function curves 
(figure 6.). 
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The controversy of the impact of epidural analgesia on the incidence of 
cardiac morbidity in non-cardiac surgery. 
"Impressed by the association of operation and coronary artery occlusion in 
patients over 50 years of age" Master et. al [1937] of Mount Sinai Hospital 
in New York, provided the first evidence for surgical interventions 
precipitating coronary occlusion. In this series of 35 patients who suffered 
perioperative myocardial infarction (P-MI), during the period 1931 to 1937, 
characteristically more than 50'Yo of these P-MI's occurred within three 
days of surgery, 60% were silent, associated with a high (66%) mortality and 
post-mortem findings suggested that thrombosis occurred on underlying 
atherosclerotic plaques. 
Sixty years on, in the 1990's, we are still plagued with the increased risk of 
peri-operative morbidity and mortality associated with coronary artery 
disease (CAD). This is evidenced by the strong correlation between recent 
myocardial infarction and re-infarction or death following non-cardiac 
surgery. Mangano et al. [1990] estimated a 41'Yo incidence of postoperative 
myocardial ischemia in patients who were at risk of or with known CAD 
following non-cardiac surgery. In this study, postoperative myocardial 
ischaemia was the only multivariate predictor of an adverse post-operative 
cardiac event, with a 9.2 odds ratio for an adverse ischaemic event 
(myocardial infarction or unstable angina) within 6 months of surgery and an 
18% reported incidence of adverse cardiac events within the first 6 months 
following surgery. The inability to show history of a recent myocardial 
infarction, pre-operative or intra-operative ischaemia, as independent 
predictors of adverse cardiac events following non-cardiac surgery in this 
study may reflect the improved pre-operative work up and stratification of 
patients who are at risk, or known to have CAD, with appropriate referral of 
the patients for revascularisation prior to their non-cardiac surgery, 
according to the recent American College of Cardiology / American Heart 
Association (ACC/ AHA) Task Force on practice guidelines [1996], as well as 
optimal intra-operative anaesthetic management. 
Ischaemic injury is, furthermore, also responsible for a significant delay in 
extubation and hospital discharge, an impaired quality of life and the 
consumption of a disproportionate amount of health resources. These 
increased expenses in the non-cardiac surgical patients who suffers P-MI 
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is estimated at an additional hospital cost estimated at US$10,000 -
$20,000 per patient [Kalish et. al, 1995]. 
The optimal anaesthetic and analgesic management of patients at risk of a 
cardiac event following surgery still remains undefined. However, if we are 
to continue making an impact on reducing the incidence of adverse 
perioperative ischaemic events in patients with CAD who undergo non-cardiac 
surgery, then we as anaesthetists should assume the role of perioperative 
physicians and place emphasis of patient management on the entire peri-
operative and especially the post-operative period. 
Management should focus on risk stratification, a multimodal therapeutic 
approach to prophylaxis and treatment of ischaemia and improved detection 
of peri-operative myocardial ischaemia to allow prompt therapeutic 
intervention. The fact that the majority of atherosclerotic coronary lesions 
are dynamic in nature [Blomberg et. al, 1990] and that vasoconstriction and 
increased shear stress induced by sympathetic activation may rupture 
unstable coronary lesions exposing the underlying lipid and collagen, leading 
to secondary activation of the coagulation cascade, motivates us to place 
emphasis on two areas of peri-operative management in the patient at risk of 
an adverse peri-operative ischaemic event, namely a reduction in sympathetic 
activation and a reduction in secondary platelet and coagulation cascade 
activation. 
Modulation of the sympathetic nervous system can be done with pre-
operative medication using a2-agonists, peri-operative use of p-antagonists 
[Mangano et. al, 1996], superlative peri-operative analgesia with the use of 
opioids and regional anaesthetic techniques. 
Separate to the indirect effect of analgesia on limiting sympathetic outflow, 
there is now increasing evidence that opioids may have a direct myocardial 
protective effect, through the mediation of ischaemic preconditioning by 
delta !-opioid receptors [Schultz, 1998]. 
Therapies aimed at preventing postoperative hypercoagulability include the 
use of regional anaesthetic techniques [Rosenfeld et. al, 1993], the 
postoperative use of non-steroidal anti-inflammatory agents e.g. ketorolac 
[Beattie et. al, 1997], aspirin and possibly more specific platelet antagonists, 
e.g. glycoprotein IIb/IIIa receptor antagonists. 
Do the experimental and clinical data regarding high-TEA (Tl-4) techniques 
in CABG surgery shed any light on the continued controversy of whether 
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regional anesthetic techniques have the ability to reduce cardiac morbidity 
in non-cardiac surgery or not?. 
A full discussion of this topic falls outside the realm of this paper. 
Sympathectomy by epidural anaesthesia in the low thoracic (e.g. T71s) or 
lumbar segments may result in diastolic hypotension, with a reduction in 
coronary perfusion pressure. Furthermore, the T1-4 segments may remain 
unanaesthetised when this lower epidural route is used. In addition to the 
reduction in coronary perfusion pressure, hypotension may also induce a 
baroreceptor reflex-induced compensatory hyperactivity of these 
unanaesthetised sympathetic nerve segments [Taniguchi et. al, 1997]. 
Remembering that these last two mentioned changes may be detrimental, it 
is then not that surprising that studies [Baron et. al, 1991; Bode et. al, 1996; 
Bois et. al, 1997] have failed to show any benefit by regional anaesthesia in 
reducing the incidence of peri-operative myocardial morbidity. This is in 
contrast to the earlier studies by Yeager et. al [1987] and Tuman et. al 
[1991] who did show a reduction in cardiac morbidity with regional 
anaesthetic techniques. These earlier trials have also been criticised for 
their methodological limitations. 
There is clearly no substantial, consistent evidence from these clinical trials 
to support benefit by regional anaesthesia in reducing the incidence of peri-
operative myocardial morbidity and in fact the largest prospective, 
randomised trial to-date by Bode et al. [1996] showed an increasing trend in 
cardiac morbidity in those patients randomised to neuraxial regional 
anaesthetic techniques. As a consequence controversy continues to surround 
the role of epidural analgesia in the prevention of perioperative cardiac 
morbidity in non-cardiac surgery. 
The increased sympathetic outflow and increased shear stress associated 
with unanaesthetised sympathetic segments (T1-4) during lumbar or low-
thoracic epidural techniques may result in an exaggerated response to 
adrenergic stimuli, with excessive vasoconstriction in the presence of pre-
existent endothelial dysfunction. This vasoconstriction may cause plaque 
fissuring in atherosclerotic lesions that have an unstable angina-prone 
anatomical composition, i.e. unstable lipid bullae. This primary event then 
exposes subendothelial collagen and lipids which are known potent 
activators of the coagulation cascade (secondary event). 
The suggestion that non-critical, unstable lesions may predispose to P-MI 
and that major peri-operative myocardial morbidity following non-cardiac 
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surgery is at least partly due to coronary thrombosis, suggests that highly 
selective cardiac sympathectomy (T1-4), through selective vasodilation of 
atherosclerotic vessels and through the reduction of increased shear 
stress may prevent the primary incident, namely plaque fissuring - and 
therefore play a role in the prevention of P-MI in non-cardiac surgery. 
Fujita et. al [1996] showed that TEA lessened regional ischaemia induced by 
intracoronary injection of endothelin, in a dog model. This suggests that 
TEA at a high-thoracic level may provide protection against increased 
circulating levels of endogenous stress factors, precipitated by surgery at a 
site removed from the epidural. 
With regards to the attempt to reduce cardiac morbidity in high risk 
patients undergoing non-cardiac surgery, it may be that epidural catheters 
have been "ma/positioned in these previous studies, and that the ideal 
location of an epidural in these patients needs reconsideration. 
Positioning the epidural at Ti-4, away from the site of surgery, for a highly 
selective cardiac sympathectomy, may be more suited for the prevention of 
cardiac morbidity than current neuraxial techniques in non-cardiac surgery, 
where the epidural is sited at the level of the surgical incision. This high-
TEA should then be combined with a general anaesthetic technique that 
uses the newer more potent opioids e.g. remifentanil for attenuation of the 
surgically-induced intra-operative stress response, or even more 
controversial, the high-TEA should be combined with a second epidural at 
the level of surgery (in an attempt to maintain the other beneficial effects 
of neuraxial techniques that are known to occur in non-cardiac surgery -
namely, increased vascular graft patency, reduced pulmonary dysfunction 
and decreased rate of infection etc.). 
We await trials that provide highly selective cardiac sympathectomy by 
TEA at T1-4 (distant from the surgical site), in the high-risk non-cardiac 
surgical patient population in the hope that this will finally resolve the 
controversial issue of whether or not regional anaesthetic techniques 
reduce cardiac morbidity in patients undergoing non-cardiac surgery. 
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VI. FUTURE 
The promising results obtained in this pilot study have lead to the 
implementation of a larger (n = 90), prospectively randomised clinical trial 
investigating the role of TEA in the setting of coronary artery bypass 
graft surgery. 
This trial has been designed with emphasis on; 
• finding the optimal local anaesthetic dose, as well as the comparison of 
bupivacaine to the newer local anaesthetic agent, ropivacaine 
• utilising more concrete endpoints that will reflect whether TEA may 
impact patient outcome and patient quality of life - these endpoints 
include; 
* peri-operative myocardial infarction 
* peri-operative hypercoagulability as assessed by 
thromboelastographic studies and its possible contribution to 
early graft occlusion as assessed by coronary angiography at 4-6 
weeks post-surgery. 
In our pilot study Holter monitoring showed an increased incidence of 
post-operative ventricular arrhythmia (VPBs) formation compared to pre-
operative values. This may be related to ischaemia-reperfusion and was 
evidenced in both the TEA (17.9 vs. 1517.4 VPBs) and the GA groups (651.2 
vs. 932.7 VPBs). No statistical difference was, however, shown between 
the groups. We intend to compare bupivacaine with ropivacaine in TEA, as 
it may be that ischaemia-reperfusion injury following aorta cross-clamping 
may benefit from the lower cardiotoxicity profile of ropivacaine and 
therefore a reduction in the incidence of these postoperative arrhythmias. 
A more selective group of patients will be investigated in this larger trial. 
This group will include patients undergoing coronary artery bypass graft 
surgery using one or more arterial anastomosis (i.e. left and / or right 
internal mammary artery and/ or radial artery). The reasoning behind this 
is that traditionally multiple arterial bypass grafts have been regarded to 
be at increased risk of peri-operative morbidity. This is due to a 
propensity for the thicker walled, muscular arterial grafts to develop 
vasospasm, and subsequent ischaemia. The superior patency rates of the 
left internal mammary artery graft, however, suggests that arterial grafts 
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should remain patent for a longer period than saphenous vein grafts and 
therefore warrants studies of anaesthetic and surgical techniques that 
may reduce the incidence of arterial graft spasm. 
A "sneak preview" of the data collected to date, in this larger trial will be 
discussed below, but please note that it is incomplete, and that no 
statistical analysis has been done. These preliminary data suggest that; 
• intraoperative control of noradrenaline release is less well controlled in 
the GA group. Furthermore, despite an increase in the local 
anaesthetic infusion dose from 0.1% to 0.125% bupivacaine we still 
show a similar profile in post-operative noradrenaline levels, with 
noradrenaline levels rising above the upper reference range at 72-
hours following CPB. Whether this is tachyphylaxis, or increased 
stress with active mobilisation remains to be elucidated. 
10.5 --0- GA mean 
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• With the use of peri-operative thromboelastography we investigated 
the influence of TEA on the dynamic coagulation process. The maximal 
amplitude component of a TEG correlates with fibrinogen levels and 
platelet activity. It was our expectation to find an increase in the 
fibrinogen, an acute phase protein, component in the GA group. In an 
attempt to differentiate the contribution by the platelet and fibrinogen 
components to postoperative hypercoagulability, and an increased 
maximum amplitude, we added Reopro® [platelet glycoprotein IIb/IIIa 
antagonist] to a duplicate TEG cup. We, however, observed no 
difference in maximal amplitude components between groups. 
A striking observation was however made and that was that there was a 
significant hyperfibrinolytic process (as measured by a lysis index at 
30- minutes) in the TEA group during the late postoperative period 
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(after 24- hours - see figure below). This effect was maintained above 
baseline values for the first 5 post-operative days in which TEG's were 
performed. In comparison the GA group shows rapid loss of this 
fibrinolytic process after 48- hours. 
This hyperfibrinolytic pattern witnessed in the TEA group is suggestive 
of an active process. It may be that a repair process is activated and 
maintained in the TEA group, but not evidenced in or rapidly lost in the 
GA group. The origins of this is yet unknown - but we suspect 
neutrophilic activity may contribute to this. Neutrophils are often 
described as possessing 'two-faces'. When activated in the immediate 
per-operative period become "aggressor" cells and promote the 
inflammatory response. However, in the later post-operative period 
these aggressor cells now become "repairer" cells and may promote 
fibrinolysis. This repair process may be through the secretion of a 
possible fibrinolytic agent and the stepped process of fibrinolysis on a 
TEG recording suggests that a these agents are released in little 
boluses, possibly from granules. 
In the GA group, we see a greater stress response to surgery, with 
resultant increased levels of PAI-1 or other yet-unknown antagonists 
that oppose this hyperfibrinolytic process induced by repair cells. 
Whether this promotion of a hyperfibrinolytic process by TEA will 
translate into improved graft patency rates, and whether this is the 
process whereby epidural analgesia promotes graft patency in 
peripheral vascular surgery, is not established yet. However, it seems to 
hold promise. 
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On reviewing the literature and studying the results of our pilot study, it 
seems that numerous subgroups of patients undergoing cardiac surgery 
may benefit from TEA, and would warrant further investigation. These 
include the following groups of patients; 
• patients undergoing MIDCAB surgery - where the inability to arrest the 
heart and thus an inability to use conventional myocardial protective 
methods is seen due to not using CPB 
• patients with poor distal run-off in their native coronary arteries -
these patients show a high propensity to occlude their bypass grafts 
• patients with exaggerated endothelial dysfunction - e.g. diabetic 
patients, who would benefit from direct vasodilatory effects of TEA 
• patients with left ventricular hypertrophy (e.g. aortic stenosis) -
regional anaesthesia has traditionally been regarded as a contra-
indication for in these patients undergoing non-cardiac surgery. In 
cardiac surgery, these patients often exhibit poor postoperative 
outcome due to the difficulty to provide adequate myocardial protection 
of the hypertrophic myocardium. The improved distribution of 
myocardial blood flow towards the subendocardium by TEA may prove 
valuable during administration of cardioplegia in this group of patients. 
• congenital heart disease - the high incidence of pulmonary hypertensive 
crises evidenced in the postoperative period of children having 
undergone congenital heart surgery may also benefit from 
sympatholysis, and from stress response attenuation that is maintained 
into the postoperative period. Furthermore, patients with spelling 
episodes (e.g. Tetrallogy of Fallot) may also benefit from the 
sympatholytic effects of TEA. 
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VII. CONCLUSION 
The choice of anaesthetic technique may significantly benefit and impact the 
continual strive to improve patient care and meet the economic constraints 
placed on health care resources. This choice has the potential of reducing 
the incidence of adverse haemodynamic, metabolic, immunologic, and 
hemostatic alterations, and thereby potentially reducing morbidity and 
mortality rates. The choice of anaesthetic technique may, furthermore, 
facilitate early extubation, accelerate convalescence and promote early 
discharge of the patient following both cardiac and non-cardiac surgery. 
The optimal anaesthetic technique in cardiac and non-cardiac surgery, 
however, still remains undefined. This dissertation suggests that regional 
anaesthetic and analgesic techniques, when used correctly, in the 
immediate per-operative setting and probably even more importantly in 
the post-operative period of cardiac surgery may, in addition to the 
provision of superlative analgesia, reduce surgical stress-induced 
alterations of organ function and thereby contribute to reduced peri-
operative morbidity and accelerated recovery from cardiac surgery. 
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